{"gene":"PDK4","run_date":"2026-06-10T05:19:53","timeline":{"discoveries":[{"year":1996,"finding":"PDK4 encodes a fourth pyruvate dehydrogenase kinase isoenzyme that phosphorylates the E1alpha subunit of the mitochondrial pyruvate dehydrogenase complex (PDC), thereby inhibiting PDC activity and suppressing pyruvate oxidation. Biochemical analyses of recombinant PDK4 protein confirmed this enzymatic activity.","method":"Positional cloning, recombinant protein expression, biochemical activity assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct biochemical reconstitution of enzymatic activity with recombinant protein, foundational characterization paper replicated extensively","pmids":["8798399"],"is_preprint":false},{"year":2000,"finding":"High-fat feeding selectively upregulates PDK4 protein expression in slow-twitch (soleus) skeletal muscle, and this increased PDK4 expression is associated with markedly reduced sensitivity of PDK activity to inhibition by pyruvate, demonstrating that PDK4 isoform switching underlies altered regulatory characteristics of PDK in response to dietary fat.","method":"Western blot with isoform-specific antibodies, PDK activity assays with varying pyruvate concentrations, dietary intervention","journal":"Diabetes","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — protein-level isoform identification plus functional PDK activity measurement, single lab","pmids":["10905486"],"is_preprint":false},{"year":2002,"finding":"PDK4 mRNA and protein are coordinately upregulated across heart, skeletal muscle, and white adipose tissue during mammalian hibernation, coinciding with metabolic fuel switching from carbohydrate to fatty acid oxidation. PDK4 inhibits pyruvate dehydrogenase to minimize carbohydrate oxidation and allow fatty acid combustion.","method":"Quantitative mRNA analysis, Western blot, tissue-specific expression profiling across hibernation states","journal":"Physiological genomics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multi-tissue protein and mRNA quantification with physiological context, single lab","pmids":["11842126"],"is_preprint":false},{"year":2004,"finding":"Insulin suppresses PDK4 mRNA expression in rat skeletal muscle predominantly through insulin signaling rather than through reduction of plasma free fatty acids (FFA); Intralipid infusion to prevent FFA decline blocked only ~20% of insulin-mediated PDK4 suppression, establishing that insulin acts on PDK4 expression largely independent of circulating FFA.","method":"Euglycemic-hyperinsulinemic clamp, Intralipid infusion, quantitative RT-PCR, Western blot in rat skeletal muscle","journal":"American journal of physiology. Endocrinology and metabolism","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo euglycemic clamp with controlled FFA manipulation, single lab but multiple treatment groups","pmids":["15026305"],"is_preprint":false},{"year":2008,"finding":"CD36-mediated fatty acid uptake upregulates FoxO1 protein levels and activity in muscle cells, which in turn induces PDK4 expression to suppress glucose oxidation. CD36 knockdown blunts fasting induction of FoxO1 and PDK4 in vivo. This CD36-dependent regulation of FoxO1/PDK4 is mediated through the nuclear receptor PPARdelta/beta.","method":"CD36 overexpression/knockdown in C2C12 cells, in vivo fasting experiments with CD36-null and PPARdelta/beta-null mice, fatty acid flux manipulation","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal gain/loss-of-function in vitro and in vivo, multiple orthogonal methods, replicated across two KO models","pmids":["18308721"],"is_preprint":false},{"year":2008,"finding":"E2F1 directly transcriptionally activates PDK4 gene expression by binding to two overlapping E2F binding sites in the PDK4 promoter. Rb inactivation induces PDK4 and enriches E2F1 occupancy at the PDK4 promoter. E2F1 enforced expression suppresses glucose oxidation in myoblasts, and E2F1 loss blunts PDK4 expression and improves myocardial glucose oxidation in vivo.","method":"Chromatin immunoprecipitation (ChIP), promoter transactivation assays with E2F site mutations, E2F1 KO mice, enforced E2F1 expression, Rb inactivation","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — ChIP confirmed E2F1 occupancy, E2F binding site mutagenesis abrogated transactivation, in vivo KO phenotype, multiple orthogonal methods","pmids":["18667418"],"is_preprint":false},{"year":2009,"finding":"Thyroid hormone (T3) induces PDK4 gene expression through two thyroid hormone receptor beta binding sites in the rat PDK4 promoter. PGC-1alpha acts as a transcriptional coactivator in this regulation: T3 increases PGC-1alpha abundance and its association with the PDK4 promoter, and PGC-1alpha knockdown diminishes T3-mediated PDK4 induction.","method":"Promoter binding site identification, ChIP, PGC-1alpha siRNA knockdown in primary rat hepatocytes, T3 administration to hypothyroid rats","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — ChIP showing coactivator recruitment, siRNA knockdown rescue, identified specific TRbeta binding sites, multiple methods in one study","pmids":["19948729"],"is_preprint":false},{"year":2010,"finding":"Epinephrine induces PDK4 mRNA expression in rat white adipose tissue through a p38 MAPK and PPARgamma-dependent pathway. Inhibition of p38 MAPK with SB202190 attenuates epinephrine-mediated PDK4 induction without affecting lipolysis, identifying p38 MAPK as a specific regulator of PDK4 in adipose tissue.","method":"Ex vivo/in vivo epinephrine treatment, p38 MAPK inhibitor SB202190, PPARgamma inhibitor, AMPK activators, quantitative mRNA analysis in rat adipose tissue","journal":"American journal of physiology. Cell physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological pathway dissection with multiple inhibitors, single lab","pmids":["20739620"],"is_preprint":false},{"year":2011,"finding":"ErbB2/Erk signaling suppresses PDK4 expression to maintain pyruvate dehydrogenase (PDH) flux in ECM-attached cells. ECM detachment increases PDK4 expression in an Erk-dependent manner; overexpression of PDK4 in ECM-detached cells suppresses ErbB2-mediated ATP rescue and in attached cells decreases PDH flux, de novo lipogenesis, and cell proliferation.","method":"ErbB2 overexpression, EGF stimulation, Erk pathway manipulation, PDK4 overexpression, metabolic flux analysis, lipogenesis measurement, cell proliferation assays","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (signaling, metabolic flux, lipogenesis, proliferation), gain- and loss-of-function, clear mechanistic pathway placement","pmids":["21852536"],"is_preprint":false},{"year":2011,"finding":"C/EBPbeta directly induces PDK4 gene expression through two C/EBPbeta binding sites in the Pdk4 promoter and reduces PDC activity. C/EBPbeta also participates in thyroid hormone (T3)-mediated PDK4 induction: T3 increases C/EBPbeta abundance, and C/EBPbeta siRNA knockdown diminishes T3 induction of PDK4.","method":"Promoter transactivation assays, C/EBPbeta binding site identification, siRNA knockdown in primary rat hepatocytes, PDC activity measurement","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — identified binding sites, siRNA knockdown, enzymatic activity measurement, single lab","pmids":["21586575"],"is_preprint":false},{"year":2012,"finding":"FOXO1 upregulates PDK4 expression in right ventricular hypertrophy, causing increased glycolysis relative to glucose oxidation and impaired right ventricular function. Dichloroacetate (a PDK4 inhibitor) chronically decreases PDK4 and FOXO1 expression, activates PDH, restores glucose oxidation, and improves cardiac output.","method":"Microarray gene expression analysis, isolated working heart perfusion, PDK4/FOXO1 protein quantification, chronic dichloroacetate treatment in vivo, cardiac output measurement","journal":"Journal of molecular medicine (Berlin, Germany)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo pharmacological intervention with functional cardiac endpoints plus human patient tissue validation, single lab","pmids":["23247844"],"is_preprint":false},{"year":2012,"finding":"A 16-base pair deletion in the 5' donor splice site of intron 10 of the PDK4 gene is genetically associated with familial dilated cardiomyopathy in Doberman Pinscher dogs. Affected dogs show mitochondrial ultrastructural abnormalities including megamitochondria and whorling.","method":"Genome-wide association study, fine-mapping, DNA sequencing, electron microscopy of myocardium","journal":"Human genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — GWAS followed by sequencing identified the causal variant, electron microscopy provided organelle-level phenotype, genetic association study","pmids":["22447147"],"is_preprint":false},{"year":2013,"finding":"Angiotensin II (ANG II) reduces cardiac glucose oxidation in part by increasing PDK4 levels and by promoting SIRT3-dependent acetylation of the pyruvate dehydrogenase (PDH) complex, reducing PDH activity. PDK4 deletion prevents ANG II-induced diastolic dysfunction and normalizes glucose oxidation to basal levels.","method":"Ex vivo heart perfusion with metabolic flux measurement, PDK4 KO mice, ANG II infusion model, PDH phosphorylation and acetylation measurements","journal":"American journal of physiology. Heart and circulatory physiology","confidence":"High","confidence_rationale":"Tier 2 / Strong — PDK4 KO rescue of functional cardiac phenotype, ex vivo metabolic flux, multiple PTM measurements, two independent mechanisms identified","pmids":["23396452"],"is_preprint":false},{"year":2014,"finding":"PDK4 protein physically binds to CREB and prevents its proteasomal degradation. Stabilized CREB then transcriptionally induces RHEB expression, which activates mTORC1 independently of AMPK or TSC2, promoting aerobic glycolysis and tumor growth.","method":"Co-immunoprecipitation, PDK4 overexpression/knockdown, CREB protein stability assay, RHEB expression analysis, mTORC1 activity measurement, xenograft tumor models","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP demonstrated PDK4-CREB interaction, downstream signaling cascade validated by multiple approaches, single lab","pmids":["25164809"],"is_preprint":false},{"year":2015,"finding":"ZBTB2 transcriptionally represses RelA/p65 expression by blocking Sp1 binding to the RelA/p65 promoter. Since RelA/p65 directly binds PGC-1alpha to decrease PDK4 transcription, ZBTB2-mediated p65 repression indirectly increases PDK4 expression, inhibits PDH, and shifts glucose metabolism toward glycolysis.","method":"Promoter reporter assays, Sp1 binding competition, ZBTB2 overexpression/knockdown, metabolite measurements (pyruvate, lactate), xenograft tumor models","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — mechanistic cascade identified with promoter assays and metabolic readouts, single lab","pmids":["25609694"],"is_preprint":false},{"year":2016,"finding":"miR-182 directly targets and suppresses PDK4 expression, thereby increasing PDH activity and promoting de novo lipogenesis from acetyl-CoA in lung cancer cells. This miR-182/PDK4 axis drives cancer cell growth partly through lipogenesis and downstream JNK-ROS signaling.","method":"miR-182 overexpression/knockdown, direct 3'UTR targeting validation, PDH activity assay, lipogenesis measurement with ACLY/FASN inhibitors, ROS and JNK pathway analysis","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct miRNA target validation, enzymatic activity assay, multiple pathway readouts, single lab","pmids":["27641336"],"is_preprint":false},{"year":2016,"finding":"Farnesoid X receptor (FXR) activation transcriptionally upregulates PDK4 as a target gene, which drives metabolic reprogramming toward aerobic glycolysis and accumulation of glycolytic intermediates to support cell proliferation during liver regeneration.","method":"FXR agonist treatment, PDK4 mRNA/protein measurement, metabolic profiling (lactate, pyruvate, glycine), liver regeneration mouse model, in vitro cell proliferation assays","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological FXR activation linked to PDK4 induction and metabolic shift, in vivo liver regeneration model, single lab","pmids":["26728993"],"is_preprint":false},{"year":2017,"finding":"PDK4 is the dominant PDK isoform in human cytotrophoblasts and its expression is substantially downregulated upon syncytialization via the hCG/cAMP/PKA signaling pathway. PDK4 knockdown reduces lactate and increases ATP, while PDK4 overexpression has opposite effects, demonstrating PDK4 controls the metabolic switch from glycolysis to oxidative phosphorylation during trophoblast differentiation.","method":"Primary human trophoblast culture, siRNA knockdown, PDK4 overexpression, lactate/ATP measurement, syncytialization assay, cAMP/PKA pathway manipulation","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — bidirectional gain/loss-of-function with metabolic readouts, signaling pathway identified, single lab","pmids":["28814762"],"is_preprint":false},{"year":2017,"finding":"PDK4 inhibition with DCA results in increased PDH activity, reduced bladder cancer cell growth, and G0-G1 phase cell cycle arrest. siRNA knockdown of PDK4 also inhibits bladder cancer cell proliferation, and DCA combined with cisplatin reduces tumor volumes in xenograft models through intratumoral necrosis.","method":"DCA pharmacological inhibition, siRNA knockdown, PDH activity assay, cell cycle analysis, xenograft tumor model","journal":"Molecular cancer therapeutics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological and genetic PDK4 inhibition with enzymatic activity readout and in vivo tumor model, single lab","pmids":["29907593"],"is_preprint":false},{"year":2018,"finding":"Adropin stimulates cardiac cells through GPR19 (a putative adropin receptor) to activate the p44/42 MAPK pathway, which decreases PDK4 expression, reduces inhibitory PDH phosphorylation, and shifts mitochondrial fuel utilization toward glucose. GPR19 depletion alone increases PDK4 expression and reduces mitochondrial respiration.","method":"Adropin stimulation of H9c2 cardiac cells, GPR19 genetic depletion, MAPK pathway pharmacological inhibition, PDK4/PDH phosphorylation Western blot, mitochondrial respiration measurement","journal":"Redox biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — receptor knockdown establishes pathway dependence, MAPK inhibition blocks effect, multiple readouts, single lab","pmids":["29909017"],"is_preprint":false},{"year":2018,"finding":"PDK4 deficiency in hepatocytes triggers pro-apoptotic signaling by causing PDK4 to lose its cytoplasmic retention of the NF-kB subunit p65. PDK4 physically interacts with p65 to retain it in the cytoplasm; loss of PDK4 allows p65 nuclear translocation, which drives TNF promoter binding and activates the TNF-TNFR1 apoptotic pathway with sustained JNK activation and ROS production.","method":"Co-immunoprecipitation (PDK4-p65 interaction), PDK4 KO mice, p65 nuclear/cytoplasmic fractionation, ChIP at TNF promoter, JNK/ROS measurement, pharmacological p65 and TNFR1 inhibition rescue experiments","journal":"Hepatology (Baltimore, Md.)","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — Co-IP established direct PDK4-p65 interaction, KO mice, ChIP at promoter, rescue by p65/TNFR1 inhibition, multiple orthogonal methods","pmids":["29603325"],"is_preprint":false},{"year":2018,"finding":"PDK4 deficiency decreases intracellular ATP levels (by reducing fatty acid oxidation), which activates AMPK, leading to phosphorylation of PDE4B. This reduces cAMP levels and consequently reduces phospho-CREB, suppressing glucagon-mediated gluconeogenic gene expression and hepatic glucose production.","method":"PDK4 KO and overexpression in hepatocytes, metabolic flux analysis (fatty acid oxidation), AMPK/PDE4B/cAMP/CREB pathway measurement, FAO inhibitor etomoxir, gluconeogenic gene expression","journal":"Diabetes","confidence":"High","confidence_rationale":"Tier 2 / Strong — metabolic flux analysis, multiple signaling intermediates validated, bidirectional PDK4 manipulation, etomoxir rescue pinpoints FAO as mechanism, single lab with multiple orthogonal methods","pmids":["30065033"],"is_preprint":false},{"year":2019,"finding":"PDK4 overexpression in myotube cultures is sufficient to promote myofiber shrinkage with enhanced protein catabolism and mitochondrial abnormalities. Blockade of PDK4 restores myotube size in cultures exposed to tumor-conditioned media, establishing a direct role for PDK4 in cancer cachexia-associated skeletal muscle atrophy.","method":"Viral-mediated PDK4 overexpression in myotube cultures, PDK4 blockade, myotube size measurement, protein catabolism assays, mitochondrial morphology analysis","journal":"FASEB journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — bidirectional gain/loss-of-function with defined cellular phenotype, single lab","pmids":["30894018"],"is_preprint":false},{"year":2019,"finding":"PDK4 overexpression causes increased fatty acid oxidation in cancer cells, and upregulated PDK4 expression indicates an overarching metabolic shift toward fatty acid utilization as energy fuel. PPARα overexpression and TTA treatment increase both fatty acid oxidation and PDK4 expression, while PDK4 overexpression itself is sufficient to drive increased fatty acid oxidation.","method":"PPARα overexpression, TTA treatment, PDK4 overexpression in MDA-MB-231 and HeLa cells, fatty acid oxidation assay, Seahorse metabolic analysis","journal":"Mitochondrion","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct PDK4 overexpression causing measurable fatty acid oxidation increase, multiple cell lines, single lab","pmids":["31351920"],"is_preprint":false},{"year":2020,"finding":"m6A modification of the PDK4 5'UTR positively regulates PDK4 translation elongation via binding with the YTHDF1/eEF-2 complex, and mRNA stability via binding with IGF2BP3. TBP transcriptionally increases METTL3 expression in cervical cancer cells. Targeted demethylation of PDK4 m6A by dm6ACRISPR decreases PDK4 expression and glycolysis.","method":"m6A-seq, YTHDF1/eEF-2/IGF2BP3 binding assays, dm6ACRISPR targeted demethylation, translation elongation assay, mRNA stability assay, glycolysis measurement, TBP ChIP at METTL3 promoter","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — m6A-seq identified modification, multiple binding partner validations, CRISPR-based targeted demethylation with functional readout, multiple orthogonal methods","pmids":["32444598"],"is_preprint":false},{"year":2020,"finding":"PDK4 drives vascular smooth muscle cell calcification by impairing autophagic flux via two mechanisms: (1) disrupting the integrity of mitochondria-associated endoplasmic reticulum membranes and impairing mitochondrial respiratory capacity, leading to decreased lysosomal V-ATPase and LDHB interaction; (2) inhibiting nuclear translocation of transcription factor EB (TFEB) to suppress lysosomal function. PDK4 also shifts VSMC metabolism toward a Warburg effect.","method":"PDK4 knockdown/overexpression in VSMCs, mitochondria-ER membrane integrity assay, V-ATPase/LDHB interaction analysis, TFEB nuclear translocation imaging, autophagic flux assay, calcium content measurement","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple mechanistic endpoints with PDK4 manipulation, identified specific molecular interactions, single lab","pmids":["33203874"],"is_preprint":false},{"year":2020,"finding":"LKB1 represses ATOH1 expression in intestinal stem cells via PDK4. LKB1 loss increases PDK4 expression and alters metabolic profile; PDK4 knockdown or DCA inhibition reduces the upregulation of ATOH1 mRNA after LKB1 knockdown and partially restores oxygen consumption rate, placing PDK4 downstream of LKB1 in intestinal stem cell fate determination.","method":"LKB1 conditional KO mice, PDK4 siRNA knockdown, DCA treatment, ATOH1 mRNA measurement, Seahorse metabolic analysis, intestinal organoid assays, RNA-seq","journal":"Gastroenterology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis established (PDK4 knockdown reverses LKB1-loss phenotype), multiple model systems, single lab","pmids":["31930988"],"is_preprint":false},{"year":2020,"finding":"PDK4 deficiency in liver promotes regeneration after partial hepatectomy by enhancing insulin/Akt signaling and activating an AMPK/FOXO1/CD36 axis: PDK4 loss reduces intracellular AMP levels, activates AMPK, which phosphorylates and activates FOXO1 to suppress CD36 expression; conversely, PDK4 overexpression suppresses AMPK and allows CD36-mediated lipid uptake. PDK4-regulated AMPK activation directly depends on intracellular AMP.","method":"PDK4 KO mice with partial hepatectomy, in vitro AMP manipulation, AMPK/FOXO1/CD36 pathway measurement, CD36 overexpression, insulin signaling (IRS1/IRS2/Akt phosphorylation), liver/body weight ratio, hepatic DNA replication","journal":"Hepatology communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — KO mouse model with multiple pathway intermediates validated, in vitro AMP mechanism, single lab","pmids":["32258946"],"is_preprint":false},{"year":2021,"finding":"PDK4 inhibits ferroptosis in pancreatic ductal carcinoma cells by blocking pyruvate dehydrogenase (PDH)-dependent pyruvate oxidation, thereby reducing fatty acid synthesis that would otherwise fuel lipid peroxidation-dependent ferroptotic death. Glucose uptake via SLC2A1 promotes glycolysis and pyruvate oxidation to facilitate ferroptosis, while PDK4 acts as the top resistance gene against this pathway.","method":"siRNA library screen targeting metabolic enzymes, PDK4 siRNA knockdown, PDH activity assay, fatty acid synthesis measurement, lipid peroxidation assay, SLC2A1 manipulation, high-fat diet mouse model","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 / Strong — unbiased siRNA library screen identified PDK4, mechanistic validation with PDH activity measurement, in vivo model confirmation, multiple orthogonal methods","pmids":["33626342"],"is_preprint":false},{"year":2017,"finding":"Progesterone induces PDK4 expression in cardiomyocytes during late pregnancy, leading to PDH inhibition (increased PDH phosphorylation) and reduced pyruvate flux into the TCA cycle, causing cardiac metabolic remodeling toward increased fatty acid oxidation and reduced glucose/lactate oxidation. Blocking PDK4 reverses these metabolic changes.","method":"13C glucose/lactate/fatty acid tracing in isolated hearts, progesterone treatment of cardiomyocytes, PDK4 blockade, PDH phosphorylation measurement, late-pregnancy mouse model","journal":"Circulation research","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — 13C isotope tracing directly measured metabolic flux, progesterone-PDK4-PDH pathway established, PDK4 blockade reversed phenotype, multiple methods","pmids":["28928113"],"is_preprint":false},{"year":2016,"finding":"Arsenic silences hepatic PDK4 expression through activation of histone methyltransferase G9a, which increases H3K9 di- and tri-methylation (H3K9me2/3) at the PDK4 promoter. G9a siRNA knockdown induces PDK4 expression, and arsenic exposure antagonizes G9a inhibitor-mediated PDK4 induction.","method":"G9a inhibitor BRD4770, Suv39H inhibitor Chaetocin, arsenic treatment, G9a siRNA knockdown, ChIP for H3K9me2/3 at PDK4 promoter, PDK4 expression measurement in HCC cells and mouse liver","journal":"Toxicology and applied pharmacology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP identified epigenetic marks at PDK4 promoter, siRNA knockdown of writer confirmed, in vivo validation, single lab","pmids":["27217333"],"is_preprint":false},{"year":2022,"finding":"PDK4 promotes mitochondrial fission through a non-canonical mechanism independent of PDC phosphorylation. A phosphoproteomic screen identified Septin 2 (SEPT2) as a PDK4 substrate; PDK4 phosphorylates SEPT2, which then acts as a receptor for DRP1 at the outer mitochondrial membrane to drive mitochondrial fragmentation. Inhibition of the PDK4-SEPT2 axis restores mitochondrial dynamics and cellular respiration in mitofusin 2-deficient cells.","method":"Phosphoproteomic screen for PDK4 substrates, non-phosphorylatable and phosphomimetic SEPT2 mutations, DRP1 localization to outer mitochondrial membrane, mitochondrial morphology imaging, mitofusin 2-deficient cell rescue, cellular respiration measurement, PDK4 KO cells with ETC toxins","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — phosphoproteomic substrate screen, gain/loss-of-function phosphomutants, reconstitution of DRP1 receptor function, functional rescue in fusion-deficient cells, multiple orthogonal methods","pmids":["35969774"],"is_preprint":false},{"year":2023,"finding":"Senescent cells upregulate PDK4, which drives aerobic glycolysis and enhanced lactate production while maintaining mitochondrial respiration. PDK4-dependent lactate promotes ROS production via NOX1, driving the senescence-associated secretory phenotype (SASP). PDK4 suppression reduces DNA damage severity and restrains SASP.","method":"PDK4 expression analysis in senescent cell lines, PDK4 inhibition/knockdown, lactate/ROS measurement, NOX1 pathway analysis, SASP factor measurement, in vivo PDK4 inhibition in tumor and aging models","journal":"Nature metabolism","confidence":"High","confidence_rationale":"Tier 2 / Strong — mechanistic pathway (PDK4→lactate→NOX1→ROS→SASP) validated with multiple readouts, in vivo confirmation, multiple orthogonal methods","pmids":["37903887"],"is_preprint":false},{"year":2022,"finding":"PDK4 overexpression promotes PDH phosphorylation, inhibits PDH activity, and changes cell metabolism after subarachnoid hemorrhage (SAH). PDK4 activity reduces ROS production and inhibits the ASK1/P38 apoptosis pathway in neurons, providing neuroprotection. PDK4 knockdown promotes ROS production, activates ASK1/P38, and induces neuronal apoptosis.","method":"siRNA PDK4 knockdown, lentiviral PDK4 overexpression, DCA PDK4 inhibition, PDH phosphorylation and activity measurement, ROS measurement, ASK1/P38 activation, neuronal apoptosis quantification, SAH rat model","journal":"Antioxidants & redox signaling","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — bidirectional PDK4 manipulation with PDH activity readout and apoptotic pathway measurement, in vivo SAH model, single lab","pmids":["34498942"],"is_preprint":false},{"year":2024,"finding":"PDK4 phosphorylates HDAC8 at Ser-39, activating HDAC8, which then deacetylates and suppresses CD20 protein expression, contributing to rituximab resistance in DLBCL. PDK4 protein localizes to both nucleus and cytoplasm in resistant cells.","method":"shRNA knockdown with RNA sequencing, immunofluorescence localization, Western blot, PDK4 phosphorylation of HDAC8 Ser-39 identified, CD20 deacetylation measurement, resistant DLBCL cell line and mouse model","journal":"Molecular cancer","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — specific phosphorylation site identified on HDAC8, downstream deacetylation of CD20 measured, functional resistance phenotype, single lab","pmids":["39004737"],"is_preprint":false},{"year":2024,"finding":"AMPK phosphorylation stimulates PDK4 expression, and SIRT1 physically interacts with PDK4 to promote glycolysis and facilitate endometrial stromal cell decidualization. Testosterone excess inhibits the AMPK/SIRT1/PDK4 pathway via androgen receptor activation, impairs PDK4 expression, and disrupts decidualization.","method":"Co-immunoprecipitation (SIRT1-PDK4 interaction), RNA-seq, PDK4 knockdown in vivo and in vitro, AMPK inhibitor/activator experiments, AR inhibition rescue, glycolysis measurement, decidualization markers (IGFBP1, PRL)","journal":"Cellular and molecular life sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP demonstrated SIRT1-PDK4 protein interaction, bidirectional PDK4 manipulation with functional decidualization phenotype, single lab","pmids":["39080028"],"is_preprint":false},{"year":2013,"finding":"HIV-1 Vpr physically interacts with the ligand-binding domain of PPARbeta/delta in vitro and in vivo, and through this interaction enhances PPARbeta/delta-mediated transcription of PDK4 (1.9-fold increase in PDK4 protein), increasing inhibitory phosphorylation of PDH E1alpha and reducing PDC activity by 47%.","method":"PPARbeta/delta knockdown, Vpr-PPARbeta/delta in vitro and in vivo binding assay, PDK4 protein and mRNA measurement, PDH E1alpha phosphorylation, PDC activity assay, oxygen consumption measurement","journal":"Molecular endocrinology (Baltimore, Md.)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct protein-protein interaction demonstrated in vitro and in vivo, PDC enzymatic activity measured, PPARbeta/delta knockdown confirmed pathway dependence","pmids":["23842279"],"is_preprint":false},{"year":2020,"finding":"WTAP mediates m6A modification of PDK4 mRNA; WTAP binds to m6A binding sites in PDK4 mRNA (confirmed by RNA pull-down assay). WTAP depletion increases PDK4 expression and suppresses colorectal cancer cell malignancy, while PDK4 silencing promotes cancer cell growth.","method":"MeRIP-qPCR for m6A quantification, RNA pull-down confirming WTAP-PDK4 mRNA interaction, shRNA knockdown of WTAP and PDK4, xenograft tumor models","journal":"Current medicinal chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — MeRIP-qPCR and RNA pull-down established WTAP-PDK4 mRNA interaction, in vivo xenograft, single lab","pmids":["36154586"],"is_preprint":false},{"year":2006,"finding":"Insulin's ability to suppress PDK4 mRNA expression in skeletal muscle is impaired in acute insulin-resistant states (induced by Intralipid or lactate infusion), concomitant with impaired insulin-stimulated phosphorylation of Akt and FOXO1, establishing that insulin suppresses PDK4 through the Akt-FOXO1 signaling axis.","method":"Euglycemic hyperinsulinemic clamp in insulin-resistant rats, Intralipid/lactate infusion, quantitative RT-PCR for PDK4, Akt and FOXO1 phosphorylation measurement","journal":"Diabetes","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo clamp study establishing Akt-FOXO1 as mediators of insulin-PDK4 regulation, single lab","pmids":["16873695"],"is_preprint":false}],"current_model":"PDK4 is a mitochondrial serine/threonine kinase that phosphorylates and inhibits the pyruvate dehydrogenase complex (PDC), thereby suppressing pyruvate oxidation and directing metabolic flux away from glucose oxidation toward fatty acid utilization; its expression is transcriptionally regulated by multiple pathways including E2F1, FOXO1, PPARs/PGC-1alpha, C/EBPbeta, thyroid hormone receptor, and HIF-1alpha, and post-transcriptionally by m6A modification (read by YTHDF1/eEF2 and IGF2BP3); beyond its canonical PDC-inhibitory role, PDK4 also acts non-canonically by phosphorylating SEPT2 to recruit DRP1 for mitochondrial fission, by retaining NF-kB p65 in the cytoplasm to suppress apoptosis, by stabilizing CREB to activate mTORC1 via RHEB, by phosphorylating HDAC8 to regulate CD20 expression, and by interacting with SIRT1 to promote glycolysis, placing PDK4 at a central nexus connecting energy metabolism, mitochondrial dynamics, cell survival signaling, and cellular senescence."},"narrative":{"mechanistic_narrative":"PDK4 is a mitochondrial serine/threonine kinase that phosphorylates the E1alpha subunit of the pyruvate dehydrogenase complex (PDC), inhibiting PDC activity to suppress pyruvate oxidation and redirect metabolic flux from carbohydrate toward fatty acid utilization [PMID:8798399, PMID:31351920]. This switch underlies physiological fuel selection across tissues, being induced by high-fat feeding in skeletal muscle, during hibernation, and during late pregnancy and progesterone signaling in the heart, and it reprograms cellular metabolism toward glycolysis or fatty acid oxidation in numerous disease and developmental contexts [PMID:10905486, PMID:11842126, PMID:28928113]. PDK4 transcription integrates a broad set of upstream signals: it is induced by E2F1, FOXO1, thyroid hormone receptor with PGC-1alpha and C/EBPbeta coactivation, FXR, and the CD36/FoxO1/PPARdelta fatty-acid-sensing axis, repressed by insulin via Akt-FOXO1 and by ErbB2/Erk signaling, and silenced epigenetically by G9a-mediated H3K9 methylation; its mRNA is additionally controlled post-transcriptionally by m6A modification read by YTHDF1/eEF2 and IGF2BP3 [PMID:15026305, PMID:18308721, PMID:18667418, PMID:19948729, PMID:21852536, PMID:21586575, PMID:26728993, PMID:32444598, PMID:27217333, PMID:16873695]. Beyond PDC inhibition, PDK4 has non-canonical activities: it phosphorylates SEPT2 to recruit DRP1 and drive mitochondrial fission [PMID:35969774], phosphorylates HDAC8 at Ser-39 to suppress CD20 [PMID:39004737], binds and stabilizes CREB to activate mTORC1 via RHEB [PMID:25164809], retains NF-kB p65 in the cytoplasm to restrain TNF-driven apoptosis [PMID:29603325], and interacts with SIRT1 to promote glycolysis [PMID:39080028]. Through these activities PDK4 controls cell survival, ferroptosis resistance, the senescence-associated secretory phenotype, tumor growth, cardiac metabolic remodeling, and vascular calcification [PMID:29603325, PMID:33626342, PMID:37903887, PMID:33203874]. A splice-site deletion in PDK4 is genetically associated with familial dilated cardiomyopathy in Doberman Pinscher dogs [PMID:22447147].","teleology":[{"year":1996,"claim":"Established PDK4 as a distinct PDH kinase isoenzyme with intrinsic enzymatic activity, answering what the gene product does at the biochemical level.","evidence":"Positional cloning and biochemical activity assay of recombinant PDK4 on PDC E1alpha","pmids":["8798399"],"confidence":"High","gaps":["Did not define isoform-specific regulatory or tissue-distribution features","No structural basis for substrate selectivity"]},{"year":2002,"claim":"Showed PDK4 is the physiological effector of carbohydrate-to-fat fuel switching, linking its induction to whole-body metabolic adaptation.","evidence":"Isoform-specific Western blot and PDK activity assays in high-fat-fed muscle and across hibernation states in multiple tissues","pmids":["10905486","11842126"],"confidence":"Medium","gaps":["Correlative induction without genetic loss-of-function in these models","Did not resolve transcriptional drivers"]},{"year":2008,"claim":"Defined the transcriptional control logic of PDK4, showing it is a direct target of E2F1 and of fatty-acid sensing through CD36/FoxO1/PPARdelta.","evidence":"ChIP, promoter mutagenesis, E2F1 KO mice, and reciprocal CD36 gain/loss-of-function in vitro and in CD36-null and PPARdelta-null mice","pmids":["18667418","18308721"],"confidence":"High","gaps":["Did not integrate the relative contribution of each input in a single tissue","Combinatorial regulation among factors not mapped"]},{"year":2009,"claim":"Extended the transcriptional network to hormonal and stress inputs, establishing TRbeta/PGC-1alpha, C/EBPbeta, p38/PPARgamma, and insulin/Akt-FOXO1 as PDK4 regulators.","evidence":"ChIP, binding-site mutagenesis, siRNA knockdown in hepatocytes, pharmacological pathway dissection in adipose, and hyperinsulinemic clamps with Akt/FOXO1 readouts","pmids":["19948729","21586575","20739620","16873695","15026305"],"confidence":"High","gaps":["Cross-talk and hierarchy among coactivators not resolved","Mostly rodent tissue, human regulation less defined"]},{"year":2011,"claim":"Placed PDK4 as a metabolic node downstream of oncogenic and adhesion signaling, where its suppression sustains PDH flux and proliferation.","evidence":"ErbB2/Erk manipulation with PDK4 gain-of-function, metabolic flux, lipogenesis, and proliferation assays in ECM-attached/detached cells","pmids":["21852536"],"confidence":"High","gaps":["Did not establish whether PDK4 acts solely via PDC here","In vivo tumor relevance not tested in this study"]},{"year":2012,"claim":"Demonstrated that PDK4 induction drives pathological cardiac metabolic remodeling and dysfunction, validated by PDK4 deletion and pharmacological inhibition.","evidence":"FOXO1-driven PDK4 in RV hypertrophy with DCA reversal; PDK4 KO rescue of ANG II diastolic dysfunction with ex vivo flux; Doberman GWAS linking a PDK4 splice variant to dilated cardiomyopathy","pmids":["23247844","23396452","22447147"],"confidence":"High","gaps":["Mechanism connecting the canine splice variant to disease at protein level unresolved","Tissue-specific contribution versus systemic effects not separated"]},{"year":2014,"claim":"Uncovered the first non-canonical PDK4 function — a kinase-independent scaffolding role stabilizing CREB to drive RHEB/mTORC1 signaling.","evidence":"Co-IP, CREB stability and RHEB expression assays, mTORC1 activity, and xenograft tumor models","pmids":["25164809"],"confidence":"Medium","gaps":["Single-lab Co-IP without reciprocal structural mapping","Whether this requires PDK4 catalytic activity not resolved"]},{"year":2017,"claim":"Established PDK4 as the controlling switch between glycolysis and oxidative phosphorylation during cellular differentiation and progesterone-driven cardiac remodeling.","evidence":"Bidirectional PDK4 manipulation with lactate/ATP readouts in trophoblasts; 13C flux tracing with PDK4 blockade in pregnancy heart model","pmids":["28814762","28928113"],"confidence":"High","gaps":["Upstream control beyond hCG/cAMP/PKA in trophoblast not fully mapped","Long-term physiological consequences not addressed"]},{"year":2018,"claim":"Revealed PDK4 as a survival and gluconeogenic regulator in liver via cytoplasmic p65 retention and an FAO/AMP/AMPK/CREB axis.","evidence":"PDK4-p65 Co-IP, KO mice, ChIP at TNF promoter, rescue by p65/TNFR1 inhibition; metabolic flux with etomoxir defining FAO-dependent AMPK/PDE4B/CREB signaling","pmids":["29603325","30065033"],"confidence":"High","gaps":["Whether p65 retention is direct kinase activity or scaffolding unresolved","Tissue specificity of the apoptotic role not delineated"]},{"year":2020,"claim":"Defined post-transcriptional m6A control of PDK4 and broadened its disease roles into autophagy-dependent vascular calcification, stem cell fate, and liver regeneration.","evidence":"m6A-seq, YTHDF1/eEF2/IGF2BP3 and WTAP binding assays, dm6ACRISPR; PDK4 manipulation in VSMC autophagy, LKB1 epistasis in intestinal stem cells, and PDK4 KO hepatectomy models","pmids":["32444598","37154586","33203874","31930988","32258946"],"confidence":"High","gaps":["Relative weight of transcriptional versus m6A control in vivo unclear","Whether non-canonical roles share a common molecular basis not addressed"]},{"year":2021,"claim":"Identified PDK4 as a dominant determinant of ferroptosis resistance, linking PDC inhibition to suppression of lipid-peroxidation substrate supply.","evidence":"Unbiased siRNA metabolic-enzyme screen, PDH activity and fatty acid synthesis assays, lipid peroxidation readouts, and high-fat diet mouse model in pancreatic carcinoma","pmids":["33626342"],"confidence":"High","gaps":["Generality across other tumor types not tested here","Interaction with established ferroptosis machinery (GPX4) not mapped"]},{"year":2022,"claim":"Demonstrated a PDC-independent kinase function: PDK4 phosphorylates SEPT2 to recruit DRP1 and drive mitochondrial fission.","evidence":"Phosphoproteomic substrate screen, SEPT2 phosphomutants, DRP1 localization, and rescue of mitochondrial dynamics in mitofusin 2-deficient cells","pmids":["35969774"],"confidence":"High","gaps":["Physiological contexts engaging this axis versus PDC inhibition not delineated","Structural basis of SEPT2 recognition unknown"]},{"year":2023,"claim":"Connected PDK4-driven glycolytic lactate to ROS-dependent senescence signaling, defining its role in the senescence-associated secretory phenotype.","evidence":"PDK4 knockdown/inhibition, lactate/ROS/NOX1 readouts, SASP measurement, and in vivo tumor and aging models","pmids":["37903887"],"confidence":"High","gaps":["Whether the lactate-NOX1 link is direct not fully resolved","Therapeutic window of PDK4 inhibition in aging not defined"]},{"year":2024,"claim":"Expanded the non-canonical phosphorylation repertoire and partner interactions, with PDK4 phosphorylating HDAC8 to suppress CD20 and interacting with SIRT1 to promote glycolysis.","evidence":"HDAC8 Ser-39 phosphorylation with CD20 deacetylation in resistant DLBCL; SIRT1-PDK4 Co-IP with bidirectional PDK4 manipulation in decidualization","pmids":["39004737","39080028"],"confidence":"Medium","gaps":["Single-lab studies without reciprocal structural validation","Whether nuclear PDK4 pool is functionally distinct from mitochondrial pool unresolved"]},{"year":null,"claim":"It remains unresolved how PDK4 partitions between its mitochondrial PDC-inhibitory role and its cytoplasmic/nuclear non-canonical activities, and what governs substrate choice among PDC, SEPT2, HDAC8, CREB, p65, and SIRT1.","evidence":"No single study reconciles the subcellular localization, catalytic-versus-scaffolding modes, and substrate selection across contexts","pmids":[],"confidence":"Low","gaps":["No unifying model for localization-dependent function","No structural determinants of non-PDC substrate selection identified","Relative in vivo contribution of canonical versus non-canonical roles unquantified"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,31,34]},{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[0,31,34]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[13,20]}],"localization":[{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[0,31]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[20]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[34]}],"pathway":[{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[0,23,28]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[13,20,21]},{"term_id":"R-HSA-1852241","term_label":"Organelle biogenesis and maintenance","supporting_discovery_ids":[31]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[20,28]},{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[32]}],"complexes":[],"partners":["PDHA1","SEPT2","DRP1","CREB","RELA","HDAC8","SIRT1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q16654","full_name":"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial","aliases":["Pyruvate dehydrogenase kinase isoform 4"],"length_aa":411,"mass_kda":46.5,"function":"Kinase that plays a key role in regulation of glucose and fatty acid metabolism and homeostasis via phosphorylation of the pyruvate dehydrogenase subunits PDHA1 and PDHA2. This inhibits pyruvate dehydrogenase activity, and thereby regulates metabolite flux through the tricarboxylic acid cycle, down-regulates aerobic respiration and inhibits the formation of acetyl-coenzyme A from pyruvate. Inhibition of pyruvate dehydrogenase decreases glucose utilization and increases fat metabolism in response to prolonged fasting and starvation. Plays an important role in maintaining normal blood glucose levels under starvation, and is involved in the insulin signaling cascade. Via its regulation of pyruvate dehydrogenase activity, plays an important role in maintaining normal blood pH and in preventing the accumulation of ketone bodies under starvation. In the fed state, mediates cellular responses to glucose levels and to a high-fat diet. Regulates both fatty acid oxidation and de novo fatty acid biosynthesis. Plays a role in the generation of reactive oxygen species. Protects detached epithelial cells against anoikis. Plays a role in cell proliferation via its role in regulating carbohydrate and fatty acid metabolism","subcellular_location":"Mitochondrion matrix","url":"https://www.uniprot.org/uniprotkb/Q16654/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/PDK4","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/PDK4","total_profiled":1310},"omim":[{"mim_id":"620702","title":"MITOCHONDRIAL CALCIUM UNIPORTER, DOMINANT-NEGATIVE SUBUNIT BETA; MCUB","url":"https://www.omim.org/entry/620702"},{"mim_id":"618722","title":"FAMILY WITH SEQUENCE SIMILARITY 210, MEMBER B; FAM210B","url":"https://www.omim.org/entry/618722"},{"mim_id":"616888","title":"TRANSMEMBRANE PROTEIN 8B; TMEM8B","url":"https://www.omim.org/entry/616888"},{"mim_id":"616302","title":"FORKHEAD BOX K1; FOXK1","url":"https://www.omim.org/entry/616302"},{"mim_id":"602527","title":"PYRUVATE DEHYDROGENASE KINASE, ISOENZYME 4; PDK4","url":"https://www.omim.org/entry/602527"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"skeletal muscle","ntpm":2154.8},{"tissue":"tongue","ntpm":1137.3}],"url":"https://www.proteinatlas.org/search/PDK4"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"Q16654","domains":[{"cath_id":"1.20.140.20","chopping":"22-182","consensus_level":"high","plddt":94.2485,"start":22,"end":182},{"cath_id":"3.30.565.10","chopping":"194-317_326-369","consensus_level":"high","plddt":93.8628,"start":194,"end":369}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q16654","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q16654-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q16654-F1-predicted_aligned_error_v6.png","plddt_mean":89.06},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=PDK4","jax_strain_url":"https://www.jax.org/strain/search?query=PDK4"},"sequence":{"accession":"Q16654","fasta_url":"https://rest.uniprot.org/uniprotkb/Q16654.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q16654/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q16654"}},"corpus_meta":[{"pmid":"32444598","id":"PMC_32444598","title":"N6-methyladenosine regulates glycolysis of cancer cells through PDK4.","date":"2020","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/32444598","citation_count":264,"is_preprint":false},{"pmid":"33626342","id":"PMC_33626342","title":"PDK4 dictates metabolic resistance to ferroptosis by suppressing pyruvate oxidation and fatty acid synthesis.","date":"2021","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/33626342","citation_count":220,"is_preprint":false},{"pmid":"8798399","id":"PMC_8798399","title":"Cloning and characterization of PDK4 on 7q21.3 encoding a fourth pyruvate dehydrogenase kinase isoenzyme in human.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8798399","citation_count":158,"is_preprint":false},{"pmid":"21852536","id":"PMC_21852536","title":"Erk regulation of pyruvate dehydrogenase flux through PDK4 modulates cell proliferation.","date":"2011","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/21852536","citation_count":153,"is_preprint":false},{"pmid":"10905486","id":"PMC_10905486","title":"Targeted upregulation of pyruvate dehydrogenase kinase (PDK)-4 in slow-twitch skeletal muscle underlies the stable modification of the regulatory characteristics of PDK induced by high-fat feeding.","date":"2000","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/10905486","citation_count":149,"is_preprint":false},{"pmid":"23396452","id":"PMC_23396452","title":"ANG II causes insulin resistance and induces cardiac metabolic switch and inefficiency: a critical role of PDK4.","date":"2013","source":"American journal of physiology. Heart and circulatory physiology","url":"https://pubmed.ncbi.nlm.nih.gov/23396452","citation_count":142,"is_preprint":false},{"pmid":"37903887","id":"PMC_37903887","title":"PDK4-dependent hypercatabolism and lactate production of senescent cells promotes cancer malignancy.","date":"2023","source":"Nature metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/37903887","citation_count":141,"is_preprint":false},{"pmid":"23247844","id":"PMC_23247844","title":"FOXO1-mediated upregulation of pyruvate dehydrogenase kinase-4 (PDK4) decreases glucose oxidation and impairs right ventricular function in pulmonary hypertension: therapeutic benefits of dichloroacetate.","date":"2012","source":"Journal of molecular medicine (Berlin, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/23247844","citation_count":130,"is_preprint":false},{"pmid":"11842126","id":"PMC_11842126","title":"Coordinate expression of the PDK4 gene: a means of regulating fuel selection in a hibernating mammal.","date":"2002","source":"Physiological genomics","url":"https://pubmed.ncbi.nlm.nih.gov/11842126","citation_count":126,"is_preprint":false},{"pmid":"31351920","id":"PMC_31351920","title":"Upregulated PDK4 expression is a sensitive marker of increased fatty acid oxidation.","date":"2019","source":"Mitochondrion","url":"https://pubmed.ncbi.nlm.nih.gov/31351920","citation_count":108,"is_preprint":false},{"pmid":"18308721","id":"PMC_18308721","title":"CD36-dependent regulation of muscle FoxO1 and PDK4 in the PPAR delta/beta-mediated adaptation to metabolic stress.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18308721","citation_count":104,"is_preprint":false},{"pmid":"16873695","id":"PMC_16873695","title":"Insulin regulation of skeletal muscle PDK4 mRNA expression is impaired in acute insulin-resistant states.","date":"2006","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/16873695","citation_count":94,"is_preprint":false},{"pmid":"29907593","id":"PMC_29907593","title":"The Role of Pyruvate Dehydrogenase Kinase-4 (PDK4) in Bladder Cancer and Chemoresistance.","date":"2018","source":"Molecular cancer therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/29907593","citation_count":93,"is_preprint":false},{"pmid":"18667418","id":"PMC_18667418","title":"Regulation of the PDK4 isozyme by the Rb-E2F1 complex.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18667418","citation_count":93,"is_preprint":false},{"pmid":"28208156","id":"PMC_28208156","title":"Oncogenic role of PDK4 in human colon cancer cells.","date":"2017","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/28208156","citation_count":92,"is_preprint":false},{"pmid":"33203874","id":"PMC_33203874","title":"PDK4 promotes vascular calcification by interfering with autophagic activity and metabolic reprogramming.","date":"2020","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/33203874","citation_count":90,"is_preprint":false},{"pmid":"22447147","id":"PMC_22447147","title":"A splice site mutation in a gene encoding for PDK4, a mitochondrial protein, is associated with the development of dilated cardiomyopathy in the Doberman pinscher.","date":"2012","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22447147","citation_count":86,"is_preprint":false},{"pmid":"30170182","id":"PMC_30170182","title":"Restoring mitochondrial biogenesis with metformin attenuates β-GP-induced phenotypic transformation of VSMCs into an osteogenic phenotype via inhibition of PDK4/oxidative stress-mediated apoptosis.","date":"2018","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/30170182","citation_count":83,"is_preprint":false},{"pmid":"29909017","id":"PMC_29909017","title":"Adropin regulates pyruvate dehydrogenase in cardiac cells via a novel GPCR-MAPK-PDK4 signaling pathway.","date":"2018","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/29909017","citation_count":76,"is_preprint":false},{"pmid":"25164809","id":"PMC_25164809","title":"PDK4 protein promotes tumorigenesis through activation of cAMP-response element-binding protein (CREB)-Ras homolog enriched in brain (RHEB)-mTORC1 signaling cascade.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25164809","citation_count":75,"is_preprint":false},{"pmid":"30213959","id":"PMC_30213959","title":"Advanced glycation end products accelerate calcification in VSMCs through HIF-1α/PDK4 activation and suppress glucose metabolism.","date":"2018","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/30213959","citation_count":74,"is_preprint":false},{"pmid":"29603325","id":"PMC_29603325","title":"Loss of PDK4 switches the hepatic NF-κB/TNF pathway from pro-survival to pro-apoptosis.","date":"2018","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/29603325","citation_count":72,"is_preprint":false},{"pmid":"30894018","id":"PMC_30894018","title":"PDK4 drives metabolic alterations and muscle atrophy in cancer cachexia.","date":"2019","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/30894018","citation_count":68,"is_preprint":false},{"pmid":"27641336","id":"PMC_27641336","title":"The microRNA-182-PDK4 axis regulates lung tumorigenesis by modulating pyruvate dehydrogenase and lipogenesis.","date":"2016","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/27641336","citation_count":68,"is_preprint":false},{"pmid":"19948729","id":"PMC_19948729","title":"Regulation of pyruvate dehydrogenase kinase 4 (PDK4) by thyroid hormone: role of the peroxisome proliferator-activated receptor gamma coactivator (PGC-1 alpha).","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19948729","citation_count":59,"is_preprint":false},{"pmid":"24837562","id":"PMC_24837562","title":"Altered promoter methylation of PDK4, IL1 B, IL6, and TNF after Roux-en Y gastric bypass.","date":"2014","source":"Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery","url":"https://pubmed.ncbi.nlm.nih.gov/24837562","citation_count":59,"is_preprint":false},{"pmid":"30323966","id":"PMC_30323966","title":"Targeting PDK4 inhibits breast cancer metabolism.","date":"2018","source":"American journal of cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/30323966","citation_count":55,"is_preprint":false},{"pmid":"32323921","id":"PMC_32323921","title":"STAT3-dependent analysis reveals PDK4 as independent predictor of recurrence in prostate cancer.","date":"2020","source":"Molecular systems biology","url":"https://pubmed.ncbi.nlm.nih.gov/32323921","citation_count":50,"is_preprint":false},{"pmid":"28928113","id":"PMC_28928113","title":"PDK4 Inhibits Cardiac Pyruvate Oxidation in Late Pregnancy.","date":"2017","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/28928113","citation_count":50,"is_preprint":false},{"pmid":"12582211","id":"PMC_12582211","title":"Reduced PDK4 expression associates with increased insulin sensitivity in postobese patients.","date":"2003","source":"Obesity research","url":"https://pubmed.ncbi.nlm.nih.gov/12582211","citation_count":50,"is_preprint":false},{"pmid":"32221619","id":"PMC_32221619","title":"Down-regulation of lncRNA CASC9 aggravates sepsis-induced acute lung injury by regulating miR-195-5p/PDK4 axis.","date":"2020","source":"Inflammation research : official journal of the European Histamine Research Society ... [et al.]","url":"https://pubmed.ncbi.nlm.nih.gov/32221619","citation_count":49,"is_preprint":false},{"pmid":"30065033","id":"PMC_30065033","title":"PDK4 Deficiency Suppresses Hepatic Glucagon Signaling by Decreasing cAMP Levels.","date":"2018","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/30065033","citation_count":48,"is_preprint":false},{"pmid":"32390009","id":"PMC_32390009","title":"Ascites-derived ALDH+CD44+ tumour cell subsets endow stemness, metastasis and metabolic switch via PDK4-mediated STAT3/AKT/NF-κB/IL-8 signalling in ovarian cancer.","date":"2020","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/32390009","citation_count":46,"is_preprint":false},{"pmid":"28594398","id":"PMC_28594398","title":"Loss of the novel mitochondrial protein FAM210B promotes metastasis via PDK4-dependent metabolic reprogramming.","date":"2017","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/28594398","citation_count":46,"is_preprint":false},{"pmid":"38001078","id":"PMC_38001078","title":"PDK4 rescues high-glucose-induced senescent fibroblasts and promotes diabetic wound healing through enhancing glycolysis and regulating YAP and JNK pathway.","date":"2023","source":"Cell death discovery","url":"https://pubmed.ncbi.nlm.nih.gov/38001078","citation_count":45,"is_preprint":false},{"pmid":"30868666","id":"PMC_30868666","title":"lncRNA PCAT19 promotes the proliferation of laryngocarcinoma cells via modulation of the miR-182/PDK4 axis.","date":"2019","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30868666","citation_count":45,"is_preprint":false},{"pmid":"32152704","id":"PMC_32152704","title":"Synovial fibroblast-derived exosomal microRNA-106b suppresses chondrocyte proliferation and migration in rheumatoid arthritis via down-regulation of PDK4.","date":"2020","source":"Journal of molecular medicine (Berlin, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/32152704","citation_count":45,"is_preprint":false},{"pmid":"35969774","id":"PMC_35969774","title":"Noncanonical PDK4 action alters mitochondrial dynamics to affect the cellular respiratory status.","date":"2022","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/35969774","citation_count":44,"is_preprint":false},{"pmid":"31930988","id":"PMC_31930988","title":"LKB1 Represses ATOH1 via PDK4 and Energy Metabolism and Regulates Intestinal Stem Cell Fate.","date":"2020","source":"Gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/31930988","citation_count":44,"is_preprint":false},{"pmid":"15026305","id":"PMC_15026305","title":"Insulin suppresses PDK-4 expression in skeletal muscle independently of plasma FFA.","date":"2004","source":"American journal of physiology. Endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/15026305","citation_count":44,"is_preprint":false},{"pmid":"30093112","id":"PMC_30093112","title":"The miR-15b-5p/PDK4 axis regulates osteosarcoma proliferation through modulation of the Warburg effect.","date":"2018","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/30093112","citation_count":43,"is_preprint":false},{"pmid":"30873027","id":"PMC_30873027","title":"Melatonin Therapy Modulates Cerebral Metabolism and Enhances Remyelination by Increasing PDK4 in a Mouse Model of Multiple Sclerosis.","date":"2019","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/30873027","citation_count":42,"is_preprint":false},{"pmid":"32258946","id":"PMC_32258946","title":"PDK4-Deficiency Reprograms Intrahepatic Glucose and Lipid Metabolism to Facilitate Liver Regeneration in Mice.","date":"2020","source":"Hepatology communications","url":"https://pubmed.ncbi.nlm.nih.gov/32258946","citation_count":41,"is_preprint":false},{"pmid":"20739620","id":"PMC_20739620","title":"Epinephrine-mediated regulation of PDK4 mRNA in rat adipose tissue.","date":"2010","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/20739620","citation_count":41,"is_preprint":false},{"pmid":"34498942","id":"PMC_34498942","title":"PDK4 Decrease Neuronal Apoptosis via Inhibiting ROS-ASK1/P38 Pathway in Early Brain Injury After Subarachnoid Hemorrhage.","date":"2022","source":"Antioxidants & redox signaling","url":"https://pubmed.ncbi.nlm.nih.gov/34498942","citation_count":40,"is_preprint":false},{"pmid":"30554191","id":"PMC_30554191","title":"Putrescine delays postovulatory aging of mouse oocytes by upregulating PDK4 expression and improving mitochondrial activity.","date":"2018","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/30554191","citation_count":40,"is_preprint":false},{"pmid":"30342991","id":"PMC_30342991","title":"MicroRNA-23a promotes colorectal cancer cell survival by targeting PDK4.","date":"2018","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/30342991","citation_count":39,"is_preprint":false},{"pmid":"32464167","id":"PMC_32464167","title":"Advanced glycation end products enhance macrophage polarization to the M1 phenotype via the HIF-1α/PDK4 pathway.","date":"2020","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/32464167","citation_count":38,"is_preprint":false},{"pmid":"34806156","id":"PMC_34806156","title":"microRNA-15b-5p shuttled by mesenchymal stem cell-derived extracellular vesicles protects podocytes from diabetic nephropathy via downregulation of VEGF/PDK4 axis.","date":"2021","source":"Journal of bioenergetics and biomembranes","url":"https://pubmed.ncbi.nlm.nih.gov/34806156","citation_count":37,"is_preprint":false},{"pmid":"32577500","id":"PMC_32577500","title":"miR-16-5p/PDK4-Mediated Metabolic Reprogramming Is Involved in Chemoresistance of Cervical Cancer.","date":"2020","source":"Molecular therapy oncolytics","url":"https://pubmed.ncbi.nlm.nih.gov/32577500","citation_count":35,"is_preprint":false},{"pmid":"25609694","id":"PMC_25609694","title":"ZBTB2 increases PDK4 expression by transcriptional repression of RelA/p65.","date":"2015","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/25609694","citation_count":34,"is_preprint":false},{"pmid":"31595421","id":"PMC_31595421","title":"Long non-coding RNA LINC00243 promotes proliferation and glycolysis in non-small cell lung cancer cells by positively regulating PDK4 through sponging miR-507.","date":"2019","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/31595421","citation_count":33,"is_preprint":false},{"pmid":"31376939","id":"PMC_31376939","title":"HIF-1α/PDK4/autophagy pathway protects against advanced glycation end-products induced vascular smooth muscle cell calcification.","date":"2019","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/31376939","citation_count":32,"is_preprint":false},{"pmid":"19051057","id":"PMC_19051057","title":"Characterization of the porcine differentially expressed PDK4 gene and association with meat quality.","date":"2008","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/19051057","citation_count":32,"is_preprint":false},{"pmid":"26740179","id":"PMC_26740179","title":"Inflammation increases pyruvate dehydrogenase kinase 4 (PDK4) expression via the Jun N-Terminal Kinase (JNK) pathway in C2C12 cells.","date":"2015","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/26740179","citation_count":32,"is_preprint":false},{"pmid":"29348870","id":"PMC_29348870","title":"Nε-carboxymethyl-lysine promotes calcium deposition in VSMCs via intracellular oxidative stress-induced PDK4 activation and alters glucose metabolism.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/29348870","citation_count":31,"is_preprint":false},{"pmid":"36448837","id":"PMC_36448837","title":"PRKCA Promotes Mitophagy through the miR-15a-5p/PDK4 Axis to Relieve Sepsis-Induced Acute Lung Injury.","date":"2022","source":"Infection and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/36448837","citation_count":30,"is_preprint":false},{"pmid":"27456910","id":"PMC_27456910","title":"Combined speed endurance and endurance exercise amplify the exercise-induced PGC-1α and PDK4 mRNA response in trained human muscle.","date":"2016","source":"Physiological reports","url":"https://pubmed.ncbi.nlm.nih.gov/27456910","citation_count":30,"is_preprint":false},{"pmid":"37224504","id":"PMC_37224504","title":"Glucocorticoid Receptors Drive Breast Cancer Cell Migration and Metabolic Reprogramming via PDK4.","date":"2023","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/37224504","citation_count":29,"is_preprint":false},{"pmid":"26728993","id":"PMC_26728993","title":"Farnesoid X receptor activation promotes cell proliferation via PDK4-controlled metabolic reprogramming.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/26728993","citation_count":29,"is_preprint":false},{"pmid":"17516843","id":"PMC_17516843","title":"Calcium signalling in the regulation of PGC-1alpha, PDK4 and HKII mRNA expression.","date":"2007","source":"Biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17516843","citation_count":29,"is_preprint":false},{"pmid":"29168312","id":"PMC_29168312","title":"Curcumin mediated down-regulation of αV β3 integrin and up-regulation of pyruvate dehydrogenase kinase 4 (PDK4) in Erlotinib resistant SW480 colon cancer cells.","date":"2017","source":"Phytotherapy research : PTR","url":"https://pubmed.ncbi.nlm.nih.gov/29168312","citation_count":29,"is_preprint":false},{"pmid":"21883960","id":"PMC_21883960","title":"The effect of continuous and interval exercise on PGC-1α and PDK4 mRNA in type I and type II fibres of human skeletal muscle.","date":"2011","source":"Acta physiologica (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/21883960","citation_count":28,"is_preprint":false},{"pmid":"36396113","id":"PMC_36396113","title":"SIRT6 inhibits hypoxia-induced pulmonary arterial smooth muscle cells proliferation via HIF-1α/PDK4 signaling.","date":"2022","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/36396113","citation_count":27,"is_preprint":false},{"pmid":"30929433","id":"PMC_30929433","title":"Geniposide Improves Glucose Homeostasis via Regulating FoxO1/PDK4 in Skeletal Muscle.","date":"2019","source":"Journal of agricultural and food chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30929433","citation_count":27,"is_preprint":false},{"pmid":"26576332","id":"PMC_26576332","title":"Altered regulation of PDK4 expression promotes antiestrogen resistance in human breast cancer cells.","date":"2015","source":"SpringerPlus","url":"https://pubmed.ncbi.nlm.nih.gov/26576332","citation_count":27,"is_preprint":false},{"pmid":"21586575","id":"PMC_21586575","title":"Regulation of pyruvate dehydrogenase kinase 4 (PDK4) by CCAAT/enhancer-binding protein beta (C/EBPbeta).","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21586575","citation_count":26,"is_preprint":false},{"pmid":"27217333","id":"PMC_27217333","title":"Arsenic silences hepatic PDK4 expression through activation of histone H3K9 methylatransferase G9a.","date":"2016","source":"Toxicology and applied pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/27217333","citation_count":26,"is_preprint":false},{"pmid":"38671369","id":"PMC_38671369","title":"Ginsenoside Rh2 shifts tumor metabolism from aerobic glycolysis to oxidative phosphorylation through regulating the HIF1-α/PDK4 axis in non-small cell lung cancer.","date":"2024","source":"Molecular medicine (Cambridge, Mass.)","url":"https://pubmed.ncbi.nlm.nih.gov/38671369","citation_count":25,"is_preprint":false},{"pmid":"34165388","id":"PMC_34165388","title":"LncRNA CASC2 Alleviates Sepsis-induced Acute Lung Injury by Regulating the miR-152-3p/PDK4 Axis.","date":"2021","source":"Immunological investigations","url":"https://pubmed.ncbi.nlm.nih.gov/34165388","citation_count":24,"is_preprint":false},{"pmid":"36797808","id":"PMC_36797808","title":"Cardiomyocyte Pdk4 response is associated with metabolic maladaptation in aging.","date":"2023","source":"Aging cell","url":"https://pubmed.ncbi.nlm.nih.gov/36797808","citation_count":23,"is_preprint":false},{"pmid":"31562244","id":"PMC_31562244","title":"Enhancing cardiac glycolysis causes an increase in PDK4 content in response to short-term high-fat diet.","date":"2019","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/31562244","citation_count":23,"is_preprint":false},{"pmid":"32489458","id":"PMC_32489458","title":"Loss of PDK4 expression promotes proliferation, tumorigenicity, motility and invasion of hepatocellular carcinoma cells.","date":"2020","source":"Journal of Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/32489458","citation_count":22,"is_preprint":false},{"pmid":"21076970","id":"PMC_21076970","title":"Effect of phase delay lighting rotation schedule on daily expression of per2, bmal1, rev-erbα, pparα, and pdk4 genes in the heart and liver of Wistar rats.","date":"2010","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21076970","citation_count":22,"is_preprint":false},{"pmid":"24398899","id":"PMC_24398899","title":"The antineoplastic effect of carnosine is accompanied by induction of PDK4 and can be mimicked by L-histidine.","date":"2014","source":"Amino acids","url":"https://pubmed.ncbi.nlm.nih.gov/24398899","citation_count":22,"is_preprint":false},{"pmid":"28814762","id":"PMC_28814762","title":"Down-regulation of PDK4 is Critical for the Switch of Carbohydrate Catabolism during Syncytialization of Human Placental Trophoblasts.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28814762","citation_count":22,"is_preprint":false},{"pmid":"33566299","id":"PMC_33566299","title":"MiR-122-5p suppresses neuropathic pain development by targeting PDK4.","date":"2021","source":"Neurochemical research","url":"https://pubmed.ncbi.nlm.nih.gov/33566299","citation_count":21,"is_preprint":false},{"pmid":"39794775","id":"PMC_39794775","title":"Validation and the role of PDK4 relevant to ferroptosis in degenerative lumbar disc disease.","date":"2025","source":"Journal of orthopaedic surgery and research","url":"https://pubmed.ncbi.nlm.nih.gov/39794775","citation_count":20,"is_preprint":false},{"pmid":"34737380","id":"PMC_34737380","title":"Sex differences in metabolic pathways are regulated by Pfkfb3 and Pdk4 expression in rodent muscle.","date":"2021","source":"Communications biology","url":"https://pubmed.ncbi.nlm.nih.gov/34737380","citation_count":20,"is_preprint":false},{"pmid":"27001465","id":"PMC_27001465","title":"CK2 inhibition induced PDK4-AMPK axis regulates metabolic adaptation and survival responses in glioma.","date":"2016","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/27001465","citation_count":20,"is_preprint":false},{"pmid":"39080028","id":"PMC_39080028","title":"Decreased AMPK/SIRT1/PDK4 induced by androgen excess inhibits human endometrial stromal cell decidualization in PCOS.","date":"2024","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/39080028","citation_count":19,"is_preprint":false},{"pmid":"33221963","id":"PMC_33221963","title":"PDK4 promotes tumorigenesis and cisplatin resistance in lung adenocarcinoma via transcriptional regulation of EPAS1.","date":"2020","source":"Cancer chemotherapy and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/33221963","citation_count":19,"is_preprint":false},{"pmid":"34220962","id":"PMC_34220962","title":"Increased Expression of PDK4 Was Displayed in Gastric Cancer and Exhibited an Association With Glucose Metabolism.","date":"2021","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/34220962","citation_count":19,"is_preprint":false},{"pmid":"37582412","id":"PMC_37582412","title":"TUG1 protects against ferroptosis of hepatic stellate cells by upregulating PDK4-mediated glycolysis.","date":"2023","source":"Chemico-biological interactions","url":"https://pubmed.ncbi.nlm.nih.gov/37582412","citation_count":19,"is_preprint":false},{"pmid":"34517782","id":"PMC_34517782","title":"MicroRNA -148 alleviates cardiac dysfunction, immune disorders and myocardial apoptosis in myocardial ischemia-reperfusion (MI/R) injury by targeting pyruvate dehydrogenase kinase (PDK4).","date":"2021","source":"Bioengineered","url":"https://pubmed.ncbi.nlm.nih.gov/34517782","citation_count":19,"is_preprint":false},{"pmid":"29294006","id":"PMC_29294006","title":"Diurnal Variation in PDK4 Expression Is Associated With Plasma Free Fatty Acid Availability in People.","date":"2018","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/29294006","citation_count":18,"is_preprint":false},{"pmid":"39004737","id":"PMC_39004737","title":"Unveiling the PDK4-centered rituximab-resistant mechanism in DLBCL: the potential of the \"Smart\" exosome nanoparticle therapy.","date":"2024","source":"Molecular cancer","url":"https://pubmed.ncbi.nlm.nih.gov/39004737","citation_count":17,"is_preprint":false},{"pmid":"33135971","id":"PMC_33135971","title":"Assessment of PDK4 and TTN gene variants in 48 Doberman Pinschers with dilated cardiomyopathy.","date":"2020","source":"Journal of the American Veterinary Medical Association","url":"https://pubmed.ncbi.nlm.nih.gov/33135971","citation_count":17,"is_preprint":false},{"pmid":"33819358","id":"PMC_33819358","title":"LINC00662 modulates cervical cancer cell proliferation, invasion, and apoptosis via sponging miR-103a-3p and upregulating PDK4.","date":"2021","source":"Molecular carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/33819358","citation_count":17,"is_preprint":false},{"pmid":"33841577","id":"PMC_33841577","title":"circCCDC66 promotes thyroid cancer cell proliferation, migratory and invasive abilities and glycolysis through the miR-211-5p/PDK4 axis.","date":"2021","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/33841577","citation_count":17,"is_preprint":false},{"pmid":"27117849","id":"PMC_27117849","title":"Capric Acid Up-Regulates UCP3 Expression without PDK4 Induction in Mouse C2C12 Myotubes.","date":"2016","source":"Journal of nutritional science and vitaminology","url":"https://pubmed.ncbi.nlm.nih.gov/27117849","citation_count":17,"is_preprint":false},{"pmid":"25794976","id":"PMC_25794976","title":"Pyruvate dehydrogenase kinase 4 (PDK4) could be involved in a regulatory role in apoptosis and a link between apoptosis and insulin resistance.","date":"2015","source":"Experimental and molecular pathology","url":"https://pubmed.ncbi.nlm.nih.gov/25794976","citation_count":17,"is_preprint":false},{"pmid":"33257740","id":"PMC_33257740","title":"microRNA-9-5p regulates the mitochondrial function of hepatocellular carcinoma cells through suppressing PDK4.","date":"2020","source":"Cancer gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/33257740","citation_count":16,"is_preprint":false},{"pmid":"38308345","id":"PMC_38308345","title":"PDK4 inhibits osteoarthritis progression by activating the PPAR pathway.","date":"2024","source":"Journal of orthopaedic surgery and research","url":"https://pubmed.ncbi.nlm.nih.gov/38308345","citation_count":15,"is_preprint":false},{"pmid":"30808993","id":"PMC_30808993","title":"High hepatic expression of PDK4 improves survival upon multimodal treatment of colorectal liver metastases.","date":"2019","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/30808993","citation_count":15,"is_preprint":false},{"pmid":"34542064","id":"PMC_34542064","title":"LncRNA HCG11 promotes 5-FU resistance of colon cancer cells through reprogramming glucose metabolism by targeting the miR-144-3p-PDK4 axis.","date":"2022","source":"Cancer biomarkers : section A of Disease markers","url":"https://pubmed.ncbi.nlm.nih.gov/34542064","citation_count":15,"is_preprint":false},{"pmid":"34715498","id":"PMC_34715498","title":"lncRNA GAS5 suppresses rheumatoid arthritis by inhibiting miR-361-5p and increasing PDK4.","date":"2021","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/34715498","citation_count":15,"is_preprint":false},{"pmid":"39177920","id":"PMC_39177920","title":"Dichloroacetate Prevents Sepsis Associated Encephalopathy by Inhibiting Microglia Pyroptosis through PDK4/NLRP3.","date":"2024","source":"Inflammation","url":"https://pubmed.ncbi.nlm.nih.gov/39177920","citation_count":14,"is_preprint":false},{"pmid":"23842279","id":"PMC_23842279","title":"HIV-1 Vpr enhances PPARβ/δ-mediated transcription, increases PDK4 expression, and reduces PDC activity.","date":"2013","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/23842279","citation_count":14,"is_preprint":false},{"pmid":"36154586","id":"PMC_36154586","title":"WTAP Mediated the N6-methyladenosine Modification of PDK4 to Regulate the Malignant Behaviors of Colorectal Cancer Cells In Vitro and In Vivo.","date":"2023","source":"Current medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/36154586","citation_count":14,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":54262,"output_tokens":10303,"usd":0.158665,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":21410,"output_tokens":5037,"usd":0.116487,"stage2_stop_reason":"end_turn"},"total_usd":0.275152,"stage1_batch_id":"msgbatch_013a8chtv3AWyTqv4z4sEF4C","stage2_batch_id":"msgbatch_01AHsuW63vinsvuTgzmQ3n62","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1996,\n      \"finding\": \"PDK4 encodes a fourth pyruvate dehydrogenase kinase isoenzyme that phosphorylates the E1alpha subunit of the mitochondrial pyruvate dehydrogenase complex (PDC), thereby inhibiting PDC activity and suppressing pyruvate oxidation. Biochemical analyses of recombinant PDK4 protein confirmed this enzymatic activity.\",\n      \"method\": \"Positional cloning, recombinant protein expression, biochemical activity assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct biochemical reconstitution of enzymatic activity with recombinant protein, foundational characterization paper replicated extensively\",\n      \"pmids\": [\"8798399\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"High-fat feeding selectively upregulates PDK4 protein expression in slow-twitch (soleus) skeletal muscle, and this increased PDK4 expression is associated with markedly reduced sensitivity of PDK activity to inhibition by pyruvate, demonstrating that PDK4 isoform switching underlies altered regulatory characteristics of PDK in response to dietary fat.\",\n      \"method\": \"Western blot with isoform-specific antibodies, PDK activity assays with varying pyruvate concentrations, dietary intervention\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — protein-level isoform identification plus functional PDK activity measurement, single lab\",\n      \"pmids\": [\"10905486\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"PDK4 mRNA and protein are coordinately upregulated across heart, skeletal muscle, and white adipose tissue during mammalian hibernation, coinciding with metabolic fuel switching from carbohydrate to fatty acid oxidation. PDK4 inhibits pyruvate dehydrogenase to minimize carbohydrate oxidation and allow fatty acid combustion.\",\n      \"method\": \"Quantitative mRNA analysis, Western blot, tissue-specific expression profiling across hibernation states\",\n      \"journal\": \"Physiological genomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multi-tissue protein and mRNA quantification with physiological context, single lab\",\n      \"pmids\": [\"11842126\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Insulin suppresses PDK4 mRNA expression in rat skeletal muscle predominantly through insulin signaling rather than through reduction of plasma free fatty acids (FFA); Intralipid infusion to prevent FFA decline blocked only ~20% of insulin-mediated PDK4 suppression, establishing that insulin acts on PDK4 expression largely independent of circulating FFA.\",\n      \"method\": \"Euglycemic-hyperinsulinemic clamp, Intralipid infusion, quantitative RT-PCR, Western blot in rat skeletal muscle\",\n      \"journal\": \"American journal of physiology. Endocrinology and metabolism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo euglycemic clamp with controlled FFA manipulation, single lab but multiple treatment groups\",\n      \"pmids\": [\"15026305\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"CD36-mediated fatty acid uptake upregulates FoxO1 protein levels and activity in muscle cells, which in turn induces PDK4 expression to suppress glucose oxidation. CD36 knockdown blunts fasting induction of FoxO1 and PDK4 in vivo. This CD36-dependent regulation of FoxO1/PDK4 is mediated through the nuclear receptor PPARdelta/beta.\",\n      \"method\": \"CD36 overexpression/knockdown in C2C12 cells, in vivo fasting experiments with CD36-null and PPARdelta/beta-null mice, fatty acid flux manipulation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal gain/loss-of-function in vitro and in vivo, multiple orthogonal methods, replicated across two KO models\",\n      \"pmids\": [\"18308721\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"E2F1 directly transcriptionally activates PDK4 gene expression by binding to two overlapping E2F binding sites in the PDK4 promoter. Rb inactivation induces PDK4 and enriches E2F1 occupancy at the PDK4 promoter. E2F1 enforced expression suppresses glucose oxidation in myoblasts, and E2F1 loss blunts PDK4 expression and improves myocardial glucose oxidation in vivo.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP), promoter transactivation assays with E2F site mutations, E2F1 KO mice, enforced E2F1 expression, Rb inactivation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — ChIP confirmed E2F1 occupancy, E2F binding site mutagenesis abrogated transactivation, in vivo KO phenotype, multiple orthogonal methods\",\n      \"pmids\": [\"18667418\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Thyroid hormone (T3) induces PDK4 gene expression through two thyroid hormone receptor beta binding sites in the rat PDK4 promoter. PGC-1alpha acts as a transcriptional coactivator in this regulation: T3 increases PGC-1alpha abundance and its association with the PDK4 promoter, and PGC-1alpha knockdown diminishes T3-mediated PDK4 induction.\",\n      \"method\": \"Promoter binding site identification, ChIP, PGC-1alpha siRNA knockdown in primary rat hepatocytes, T3 administration to hypothyroid rats\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — ChIP showing coactivator recruitment, siRNA knockdown rescue, identified specific TRbeta binding sites, multiple methods in one study\",\n      \"pmids\": [\"19948729\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Epinephrine induces PDK4 mRNA expression in rat white adipose tissue through a p38 MAPK and PPARgamma-dependent pathway. Inhibition of p38 MAPK with SB202190 attenuates epinephrine-mediated PDK4 induction without affecting lipolysis, identifying p38 MAPK as a specific regulator of PDK4 in adipose tissue.\",\n      \"method\": \"Ex vivo/in vivo epinephrine treatment, p38 MAPK inhibitor SB202190, PPARgamma inhibitor, AMPK activators, quantitative mRNA analysis in rat adipose tissue\",\n      \"journal\": \"American journal of physiology. Cell physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological pathway dissection with multiple inhibitors, single lab\",\n      \"pmids\": [\"20739620\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"ErbB2/Erk signaling suppresses PDK4 expression to maintain pyruvate dehydrogenase (PDH) flux in ECM-attached cells. ECM detachment increases PDK4 expression in an Erk-dependent manner; overexpression of PDK4 in ECM-detached cells suppresses ErbB2-mediated ATP rescue and in attached cells decreases PDH flux, de novo lipogenesis, and cell proliferation.\",\n      \"method\": \"ErbB2 overexpression, EGF stimulation, Erk pathway manipulation, PDK4 overexpression, metabolic flux analysis, lipogenesis measurement, cell proliferation assays\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (signaling, metabolic flux, lipogenesis, proliferation), gain- and loss-of-function, clear mechanistic pathway placement\",\n      \"pmids\": [\"21852536\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"C/EBPbeta directly induces PDK4 gene expression through two C/EBPbeta binding sites in the Pdk4 promoter and reduces PDC activity. C/EBPbeta also participates in thyroid hormone (T3)-mediated PDK4 induction: T3 increases C/EBPbeta abundance, and C/EBPbeta siRNA knockdown diminishes T3 induction of PDK4.\",\n      \"method\": \"Promoter transactivation assays, C/EBPbeta binding site identification, siRNA knockdown in primary rat hepatocytes, PDC activity measurement\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — identified binding sites, siRNA knockdown, enzymatic activity measurement, single lab\",\n      \"pmids\": [\"21586575\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"FOXO1 upregulates PDK4 expression in right ventricular hypertrophy, causing increased glycolysis relative to glucose oxidation and impaired right ventricular function. Dichloroacetate (a PDK4 inhibitor) chronically decreases PDK4 and FOXO1 expression, activates PDH, restores glucose oxidation, and improves cardiac output.\",\n      \"method\": \"Microarray gene expression analysis, isolated working heart perfusion, PDK4/FOXO1 protein quantification, chronic dichloroacetate treatment in vivo, cardiac output measurement\",\n      \"journal\": \"Journal of molecular medicine (Berlin, Germany)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo pharmacological intervention with functional cardiac endpoints plus human patient tissue validation, single lab\",\n      \"pmids\": [\"23247844\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"A 16-base pair deletion in the 5' donor splice site of intron 10 of the PDK4 gene is genetically associated with familial dilated cardiomyopathy in Doberman Pinscher dogs. Affected dogs show mitochondrial ultrastructural abnormalities including megamitochondria and whorling.\",\n      \"method\": \"Genome-wide association study, fine-mapping, DNA sequencing, electron microscopy of myocardium\",\n      \"journal\": \"Human genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — GWAS followed by sequencing identified the causal variant, electron microscopy provided organelle-level phenotype, genetic association study\",\n      \"pmids\": [\"22447147\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Angiotensin II (ANG II) reduces cardiac glucose oxidation in part by increasing PDK4 levels and by promoting SIRT3-dependent acetylation of the pyruvate dehydrogenase (PDH) complex, reducing PDH activity. PDK4 deletion prevents ANG II-induced diastolic dysfunction and normalizes glucose oxidation to basal levels.\",\n      \"method\": \"Ex vivo heart perfusion with metabolic flux measurement, PDK4 KO mice, ANG II infusion model, PDH phosphorylation and acetylation measurements\",\n      \"journal\": \"American journal of physiology. Heart and circulatory physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — PDK4 KO rescue of functional cardiac phenotype, ex vivo metabolic flux, multiple PTM measurements, two independent mechanisms identified\",\n      \"pmids\": [\"23396452\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"PDK4 protein physically binds to CREB and prevents its proteasomal degradation. Stabilized CREB then transcriptionally induces RHEB expression, which activates mTORC1 independently of AMPK or TSC2, promoting aerobic glycolysis and tumor growth.\",\n      \"method\": \"Co-immunoprecipitation, PDK4 overexpression/knockdown, CREB protein stability assay, RHEB expression analysis, mTORC1 activity measurement, xenograft tumor models\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP demonstrated PDK4-CREB interaction, downstream signaling cascade validated by multiple approaches, single lab\",\n      \"pmids\": [\"25164809\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"ZBTB2 transcriptionally represses RelA/p65 expression by blocking Sp1 binding to the RelA/p65 promoter. Since RelA/p65 directly binds PGC-1alpha to decrease PDK4 transcription, ZBTB2-mediated p65 repression indirectly increases PDK4 expression, inhibits PDH, and shifts glucose metabolism toward glycolysis.\",\n      \"method\": \"Promoter reporter assays, Sp1 binding competition, ZBTB2 overexpression/knockdown, metabolite measurements (pyruvate, lactate), xenograft tumor models\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mechanistic cascade identified with promoter assays and metabolic readouts, single lab\",\n      \"pmids\": [\"25609694\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"miR-182 directly targets and suppresses PDK4 expression, thereby increasing PDH activity and promoting de novo lipogenesis from acetyl-CoA in lung cancer cells. This miR-182/PDK4 axis drives cancer cell growth partly through lipogenesis and downstream JNK-ROS signaling.\",\n      \"method\": \"miR-182 overexpression/knockdown, direct 3'UTR targeting validation, PDH activity assay, lipogenesis measurement with ACLY/FASN inhibitors, ROS and JNK pathway analysis\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct miRNA target validation, enzymatic activity assay, multiple pathway readouts, single lab\",\n      \"pmids\": [\"27641336\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Farnesoid X receptor (FXR) activation transcriptionally upregulates PDK4 as a target gene, which drives metabolic reprogramming toward aerobic glycolysis and accumulation of glycolytic intermediates to support cell proliferation during liver regeneration.\",\n      \"method\": \"FXR agonist treatment, PDK4 mRNA/protein measurement, metabolic profiling (lactate, pyruvate, glycine), liver regeneration mouse model, in vitro cell proliferation assays\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological FXR activation linked to PDK4 induction and metabolic shift, in vivo liver regeneration model, single lab\",\n      \"pmids\": [\"26728993\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"PDK4 is the dominant PDK isoform in human cytotrophoblasts and its expression is substantially downregulated upon syncytialization via the hCG/cAMP/PKA signaling pathway. PDK4 knockdown reduces lactate and increases ATP, while PDK4 overexpression has opposite effects, demonstrating PDK4 controls the metabolic switch from glycolysis to oxidative phosphorylation during trophoblast differentiation.\",\n      \"method\": \"Primary human trophoblast culture, siRNA knockdown, PDK4 overexpression, lactate/ATP measurement, syncytialization assay, cAMP/PKA pathway manipulation\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — bidirectional gain/loss-of-function with metabolic readouts, signaling pathway identified, single lab\",\n      \"pmids\": [\"28814762\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"PDK4 inhibition with DCA results in increased PDH activity, reduced bladder cancer cell growth, and G0-G1 phase cell cycle arrest. siRNA knockdown of PDK4 also inhibits bladder cancer cell proliferation, and DCA combined with cisplatin reduces tumor volumes in xenograft models through intratumoral necrosis.\",\n      \"method\": \"DCA pharmacological inhibition, siRNA knockdown, PDH activity assay, cell cycle analysis, xenograft tumor model\",\n      \"journal\": \"Molecular cancer therapeutics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological and genetic PDK4 inhibition with enzymatic activity readout and in vivo tumor model, single lab\",\n      \"pmids\": [\"29907593\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Adropin stimulates cardiac cells through GPR19 (a putative adropin receptor) to activate the p44/42 MAPK pathway, which decreases PDK4 expression, reduces inhibitory PDH phosphorylation, and shifts mitochondrial fuel utilization toward glucose. GPR19 depletion alone increases PDK4 expression and reduces mitochondrial respiration.\",\n      \"method\": \"Adropin stimulation of H9c2 cardiac cells, GPR19 genetic depletion, MAPK pathway pharmacological inhibition, PDK4/PDH phosphorylation Western blot, mitochondrial respiration measurement\",\n      \"journal\": \"Redox biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — receptor knockdown establishes pathway dependence, MAPK inhibition blocks effect, multiple readouts, single lab\",\n      \"pmids\": [\"29909017\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"PDK4 deficiency in hepatocytes triggers pro-apoptotic signaling by causing PDK4 to lose its cytoplasmic retention of the NF-kB subunit p65. PDK4 physically interacts with p65 to retain it in the cytoplasm; loss of PDK4 allows p65 nuclear translocation, which drives TNF promoter binding and activates the TNF-TNFR1 apoptotic pathway with sustained JNK activation and ROS production.\",\n      \"method\": \"Co-immunoprecipitation (PDK4-p65 interaction), PDK4 KO mice, p65 nuclear/cytoplasmic fractionation, ChIP at TNF promoter, JNK/ROS measurement, pharmacological p65 and TNFR1 inhibition rescue experiments\",\n      \"journal\": \"Hepatology (Baltimore, Md.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — Co-IP established direct PDK4-p65 interaction, KO mice, ChIP at promoter, rescue by p65/TNFR1 inhibition, multiple orthogonal methods\",\n      \"pmids\": [\"29603325\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"PDK4 deficiency decreases intracellular ATP levels (by reducing fatty acid oxidation), which activates AMPK, leading to phosphorylation of PDE4B. This reduces cAMP levels and consequently reduces phospho-CREB, suppressing glucagon-mediated gluconeogenic gene expression and hepatic glucose production.\",\n      \"method\": \"PDK4 KO and overexpression in hepatocytes, metabolic flux analysis (fatty acid oxidation), AMPK/PDE4B/cAMP/CREB pathway measurement, FAO inhibitor etomoxir, gluconeogenic gene expression\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — metabolic flux analysis, multiple signaling intermediates validated, bidirectional PDK4 manipulation, etomoxir rescue pinpoints FAO as mechanism, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"30065033\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"PDK4 overexpression in myotube cultures is sufficient to promote myofiber shrinkage with enhanced protein catabolism and mitochondrial abnormalities. Blockade of PDK4 restores myotube size in cultures exposed to tumor-conditioned media, establishing a direct role for PDK4 in cancer cachexia-associated skeletal muscle atrophy.\",\n      \"method\": \"Viral-mediated PDK4 overexpression in myotube cultures, PDK4 blockade, myotube size measurement, protein catabolism assays, mitochondrial morphology analysis\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — bidirectional gain/loss-of-function with defined cellular phenotype, single lab\",\n      \"pmids\": [\"30894018\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"PDK4 overexpression causes increased fatty acid oxidation in cancer cells, and upregulated PDK4 expression indicates an overarching metabolic shift toward fatty acid utilization as energy fuel. PPARα overexpression and TTA treatment increase both fatty acid oxidation and PDK4 expression, while PDK4 overexpression itself is sufficient to drive increased fatty acid oxidation.\",\n      \"method\": \"PPARα overexpression, TTA treatment, PDK4 overexpression in MDA-MB-231 and HeLa cells, fatty acid oxidation assay, Seahorse metabolic analysis\",\n      \"journal\": \"Mitochondrion\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct PDK4 overexpression causing measurable fatty acid oxidation increase, multiple cell lines, single lab\",\n      \"pmids\": [\"31351920\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"m6A modification of the PDK4 5'UTR positively regulates PDK4 translation elongation via binding with the YTHDF1/eEF-2 complex, and mRNA stability via binding with IGF2BP3. TBP transcriptionally increases METTL3 expression in cervical cancer cells. Targeted demethylation of PDK4 m6A by dm6ACRISPR decreases PDK4 expression and glycolysis.\",\n      \"method\": \"m6A-seq, YTHDF1/eEF-2/IGF2BP3 binding assays, dm6ACRISPR targeted demethylation, translation elongation assay, mRNA stability assay, glycolysis measurement, TBP ChIP at METTL3 promoter\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — m6A-seq identified modification, multiple binding partner validations, CRISPR-based targeted demethylation with functional readout, multiple orthogonal methods\",\n      \"pmids\": [\"32444598\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"PDK4 drives vascular smooth muscle cell calcification by impairing autophagic flux via two mechanisms: (1) disrupting the integrity of mitochondria-associated endoplasmic reticulum membranes and impairing mitochondrial respiratory capacity, leading to decreased lysosomal V-ATPase and LDHB interaction; (2) inhibiting nuclear translocation of transcription factor EB (TFEB) to suppress lysosomal function. PDK4 also shifts VSMC metabolism toward a Warburg effect.\",\n      \"method\": \"PDK4 knockdown/overexpression in VSMCs, mitochondria-ER membrane integrity assay, V-ATPase/LDHB interaction analysis, TFEB nuclear translocation imaging, autophagic flux assay, calcium content measurement\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple mechanistic endpoints with PDK4 manipulation, identified specific molecular interactions, single lab\",\n      \"pmids\": [\"33203874\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"LKB1 represses ATOH1 expression in intestinal stem cells via PDK4. LKB1 loss increases PDK4 expression and alters metabolic profile; PDK4 knockdown or DCA inhibition reduces the upregulation of ATOH1 mRNA after LKB1 knockdown and partially restores oxygen consumption rate, placing PDK4 downstream of LKB1 in intestinal stem cell fate determination.\",\n      \"method\": \"LKB1 conditional KO mice, PDK4 siRNA knockdown, DCA treatment, ATOH1 mRNA measurement, Seahorse metabolic analysis, intestinal organoid assays, RNA-seq\",\n      \"journal\": \"Gastroenterology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis established (PDK4 knockdown reverses LKB1-loss phenotype), multiple model systems, single lab\",\n      \"pmids\": [\"31930988\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"PDK4 deficiency in liver promotes regeneration after partial hepatectomy by enhancing insulin/Akt signaling and activating an AMPK/FOXO1/CD36 axis: PDK4 loss reduces intracellular AMP levels, activates AMPK, which phosphorylates and activates FOXO1 to suppress CD36 expression; conversely, PDK4 overexpression suppresses AMPK and allows CD36-mediated lipid uptake. PDK4-regulated AMPK activation directly depends on intracellular AMP.\",\n      \"method\": \"PDK4 KO mice with partial hepatectomy, in vitro AMP manipulation, AMPK/FOXO1/CD36 pathway measurement, CD36 overexpression, insulin signaling (IRS1/IRS2/Akt phosphorylation), liver/body weight ratio, hepatic DNA replication\",\n      \"journal\": \"Hepatology communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KO mouse model with multiple pathway intermediates validated, in vitro AMP mechanism, single lab\",\n      \"pmids\": [\"32258946\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"PDK4 inhibits ferroptosis in pancreatic ductal carcinoma cells by blocking pyruvate dehydrogenase (PDH)-dependent pyruvate oxidation, thereby reducing fatty acid synthesis that would otherwise fuel lipid peroxidation-dependent ferroptotic death. Glucose uptake via SLC2A1 promotes glycolysis and pyruvate oxidation to facilitate ferroptosis, while PDK4 acts as the top resistance gene against this pathway.\",\n      \"method\": \"siRNA library screen targeting metabolic enzymes, PDK4 siRNA knockdown, PDH activity assay, fatty acid synthesis measurement, lipid peroxidation assay, SLC2A1 manipulation, high-fat diet mouse model\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — unbiased siRNA library screen identified PDK4, mechanistic validation with PDH activity measurement, in vivo model confirmation, multiple orthogonal methods\",\n      \"pmids\": [\"33626342\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Progesterone induces PDK4 expression in cardiomyocytes during late pregnancy, leading to PDH inhibition (increased PDH phosphorylation) and reduced pyruvate flux into the TCA cycle, causing cardiac metabolic remodeling toward increased fatty acid oxidation and reduced glucose/lactate oxidation. Blocking PDK4 reverses these metabolic changes.\",\n      \"method\": \"13C glucose/lactate/fatty acid tracing in isolated hearts, progesterone treatment of cardiomyocytes, PDK4 blockade, PDH phosphorylation measurement, late-pregnancy mouse model\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — 13C isotope tracing directly measured metabolic flux, progesterone-PDK4-PDH pathway established, PDK4 blockade reversed phenotype, multiple methods\",\n      \"pmids\": [\"28928113\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Arsenic silences hepatic PDK4 expression through activation of histone methyltransferase G9a, which increases H3K9 di- and tri-methylation (H3K9me2/3) at the PDK4 promoter. G9a siRNA knockdown induces PDK4 expression, and arsenic exposure antagonizes G9a inhibitor-mediated PDK4 induction.\",\n      \"method\": \"G9a inhibitor BRD4770, Suv39H inhibitor Chaetocin, arsenic treatment, G9a siRNA knockdown, ChIP for H3K9me2/3 at PDK4 promoter, PDK4 expression measurement in HCC cells and mouse liver\",\n      \"journal\": \"Toxicology and applied pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP identified epigenetic marks at PDK4 promoter, siRNA knockdown of writer confirmed, in vivo validation, single lab\",\n      \"pmids\": [\"27217333\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"PDK4 promotes mitochondrial fission through a non-canonical mechanism independent of PDC phosphorylation. A phosphoproteomic screen identified Septin 2 (SEPT2) as a PDK4 substrate; PDK4 phosphorylates SEPT2, which then acts as a receptor for DRP1 at the outer mitochondrial membrane to drive mitochondrial fragmentation. Inhibition of the PDK4-SEPT2 axis restores mitochondrial dynamics and cellular respiration in mitofusin 2-deficient cells.\",\n      \"method\": \"Phosphoproteomic screen for PDK4 substrates, non-phosphorylatable and phosphomimetic SEPT2 mutations, DRP1 localization to outer mitochondrial membrane, mitochondrial morphology imaging, mitofusin 2-deficient cell rescue, cellular respiration measurement, PDK4 KO cells with ETC toxins\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — phosphoproteomic substrate screen, gain/loss-of-function phosphomutants, reconstitution of DRP1 receptor function, functional rescue in fusion-deficient cells, multiple orthogonal methods\",\n      \"pmids\": [\"35969774\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Senescent cells upregulate PDK4, which drives aerobic glycolysis and enhanced lactate production while maintaining mitochondrial respiration. PDK4-dependent lactate promotes ROS production via NOX1, driving the senescence-associated secretory phenotype (SASP). PDK4 suppression reduces DNA damage severity and restrains SASP.\",\n      \"method\": \"PDK4 expression analysis in senescent cell lines, PDK4 inhibition/knockdown, lactate/ROS measurement, NOX1 pathway analysis, SASP factor measurement, in vivo PDK4 inhibition in tumor and aging models\",\n      \"journal\": \"Nature metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — mechanistic pathway (PDK4→lactate→NOX1→ROS→SASP) validated with multiple readouts, in vivo confirmation, multiple orthogonal methods\",\n      \"pmids\": [\"37903887\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"PDK4 overexpression promotes PDH phosphorylation, inhibits PDH activity, and changes cell metabolism after subarachnoid hemorrhage (SAH). PDK4 activity reduces ROS production and inhibits the ASK1/P38 apoptosis pathway in neurons, providing neuroprotection. PDK4 knockdown promotes ROS production, activates ASK1/P38, and induces neuronal apoptosis.\",\n      \"method\": \"siRNA PDK4 knockdown, lentiviral PDK4 overexpression, DCA PDK4 inhibition, PDH phosphorylation and activity measurement, ROS measurement, ASK1/P38 activation, neuronal apoptosis quantification, SAH rat model\",\n      \"journal\": \"Antioxidants & redox signaling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — bidirectional PDK4 manipulation with PDH activity readout and apoptotic pathway measurement, in vivo SAH model, single lab\",\n      \"pmids\": [\"34498942\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"PDK4 phosphorylates HDAC8 at Ser-39, activating HDAC8, which then deacetylates and suppresses CD20 protein expression, contributing to rituximab resistance in DLBCL. PDK4 protein localizes to both nucleus and cytoplasm in resistant cells.\",\n      \"method\": \"shRNA knockdown with RNA sequencing, immunofluorescence localization, Western blot, PDK4 phosphorylation of HDAC8 Ser-39 identified, CD20 deacetylation measurement, resistant DLBCL cell line and mouse model\",\n      \"journal\": \"Molecular cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — specific phosphorylation site identified on HDAC8, downstream deacetylation of CD20 measured, functional resistance phenotype, single lab\",\n      \"pmids\": [\"39004737\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"AMPK phosphorylation stimulates PDK4 expression, and SIRT1 physically interacts with PDK4 to promote glycolysis and facilitate endometrial stromal cell decidualization. Testosterone excess inhibits the AMPK/SIRT1/PDK4 pathway via androgen receptor activation, impairs PDK4 expression, and disrupts decidualization.\",\n      \"method\": \"Co-immunoprecipitation (SIRT1-PDK4 interaction), RNA-seq, PDK4 knockdown in vivo and in vitro, AMPK inhibitor/activator experiments, AR inhibition rescue, glycolysis measurement, decidualization markers (IGFBP1, PRL)\",\n      \"journal\": \"Cellular and molecular life sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP demonstrated SIRT1-PDK4 protein interaction, bidirectional PDK4 manipulation with functional decidualization phenotype, single lab\",\n      \"pmids\": [\"39080028\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"HIV-1 Vpr physically interacts with the ligand-binding domain of PPARbeta/delta in vitro and in vivo, and through this interaction enhances PPARbeta/delta-mediated transcription of PDK4 (1.9-fold increase in PDK4 protein), increasing inhibitory phosphorylation of PDH E1alpha and reducing PDC activity by 47%.\",\n      \"method\": \"PPARbeta/delta knockdown, Vpr-PPARbeta/delta in vitro and in vivo binding assay, PDK4 protein and mRNA measurement, PDH E1alpha phosphorylation, PDC activity assay, oxygen consumption measurement\",\n      \"journal\": \"Molecular endocrinology (Baltimore, Md.)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct protein-protein interaction demonstrated in vitro and in vivo, PDC enzymatic activity measured, PPARbeta/delta knockdown confirmed pathway dependence\",\n      \"pmids\": [\"23842279\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"WTAP mediates m6A modification of PDK4 mRNA; WTAP binds to m6A binding sites in PDK4 mRNA (confirmed by RNA pull-down assay). WTAP depletion increases PDK4 expression and suppresses colorectal cancer cell malignancy, while PDK4 silencing promotes cancer cell growth.\",\n      \"method\": \"MeRIP-qPCR for m6A quantification, RNA pull-down confirming WTAP-PDK4 mRNA interaction, shRNA knockdown of WTAP and PDK4, xenograft tumor models\",\n      \"journal\": \"Current medicinal chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — MeRIP-qPCR and RNA pull-down established WTAP-PDK4 mRNA interaction, in vivo xenograft, single lab\",\n      \"pmids\": [\"36154586\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Insulin's ability to suppress PDK4 mRNA expression in skeletal muscle is impaired in acute insulin-resistant states (induced by Intralipid or lactate infusion), concomitant with impaired insulin-stimulated phosphorylation of Akt and FOXO1, establishing that insulin suppresses PDK4 through the Akt-FOXO1 signaling axis.\",\n      \"method\": \"Euglycemic hyperinsulinemic clamp in insulin-resistant rats, Intralipid/lactate infusion, quantitative RT-PCR for PDK4, Akt and FOXO1 phosphorylation measurement\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo clamp study establishing Akt-FOXO1 as mediators of insulin-PDK4 regulation, single lab\",\n      \"pmids\": [\"16873695\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"PDK4 is a mitochondrial serine/threonine kinase that phosphorylates and inhibits the pyruvate dehydrogenase complex (PDC), thereby suppressing pyruvate oxidation and directing metabolic flux away from glucose oxidation toward fatty acid utilization; its expression is transcriptionally regulated by multiple pathways including E2F1, FOXO1, PPARs/PGC-1alpha, C/EBPbeta, thyroid hormone receptor, and HIF-1alpha, and post-transcriptionally by m6A modification (read by YTHDF1/eEF2 and IGF2BP3); beyond its canonical PDC-inhibitory role, PDK4 also acts non-canonically by phosphorylating SEPT2 to recruit DRP1 for mitochondrial fission, by retaining NF-kB p65 in the cytoplasm to suppress apoptosis, by stabilizing CREB to activate mTORC1 via RHEB, by phosphorylating HDAC8 to regulate CD20 expression, and by interacting with SIRT1 to promote glycolysis, placing PDK4 at a central nexus connecting energy metabolism, mitochondrial dynamics, cell survival signaling, and cellular senescence.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"PDK4 is a mitochondrial serine/threonine kinase that phosphorylates the E1alpha subunit of the pyruvate dehydrogenase complex (PDC), inhibiting PDC activity to suppress pyruvate oxidation and redirect metabolic flux from carbohydrate toward fatty acid utilization [#0, #23]. This switch underlies physiological fuel selection across tissues, being induced by high-fat feeding in skeletal muscle, during hibernation, and during late pregnancy and progesterone signaling in the heart, and it reprograms cellular metabolism toward glycolysis or fatty acid oxidation in numerous disease and developmental contexts [#1, #2, #29]. PDK4 transcription integrates a broad set of upstream signals: it is induced by E2F1, FOXO1, thyroid hormone receptor with PGC-1alpha and C/EBPbeta coactivation, FXR, and the CD36/FoxO1/PPARdelta fatty-acid-sensing axis, repressed by insulin via Akt-FOXO1 and by ErbB2/Erk signaling, and silenced epigenetically by G9a-mediated H3K9 methylation; its mRNA is additionally controlled post-transcriptionally by m6A modification read by YTHDF1/eEF2 and IGF2BP3 [#3, #4, #5, #6, #8, #9, #16, #24, #30, #38]. Beyond PDC inhibition, PDK4 has non-canonical activities: it phosphorylates SEPT2 to recruit DRP1 and drive mitochondrial fission [#31], phosphorylates HDAC8 at Ser-39 to suppress CD20 [#34], binds and stabilizes CREB to activate mTORC1 via RHEB [#13], retains NF-kB p65 in the cytoplasm to restrain TNF-driven apoptosis [#20], and interacts with SIRT1 to promote glycolysis [#35]. Through these activities PDK4 controls cell survival, ferroptosis resistance, the senescence-associated secretory phenotype, tumor growth, cardiac metabolic remodeling, and vascular calcification [#20, #28, #32, #25]. A splice-site deletion in PDK4 is genetically associated with familial dilated cardiomyopathy in Doberman Pinscher dogs [#11].\",\n  \"teleology\": [\n    {\n      \"year\": 1996,\n      \"claim\": \"Established PDK4 as a distinct PDH kinase isoenzyme with intrinsic enzymatic activity, answering what the gene product does at the biochemical level.\",\n      \"evidence\": \"Positional cloning and biochemical activity assay of recombinant PDK4 on PDC E1alpha\",\n      \"pmids\": [\"8798399\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define isoform-specific regulatory or tissue-distribution features\", \"No structural basis for substrate selectivity\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Showed PDK4 is the physiological effector of carbohydrate-to-fat fuel switching, linking its induction to whole-body metabolic adaptation.\",\n      \"evidence\": \"Isoform-specific Western blot and PDK activity assays in high-fat-fed muscle and across hibernation states in multiple tissues\",\n      \"pmids\": [\"10905486\", \"11842126\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Correlative induction without genetic loss-of-function in these models\", \"Did not resolve transcriptional drivers\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Defined the transcriptional control logic of PDK4, showing it is a direct target of E2F1 and of fatty-acid sensing through CD36/FoxO1/PPARdelta.\",\n      \"evidence\": \"ChIP, promoter mutagenesis, E2F1 KO mice, and reciprocal CD36 gain/loss-of-function in vitro and in CD36-null and PPARdelta-null mice\",\n      \"pmids\": [\"18667418\", \"18308721\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not integrate the relative contribution of each input in a single tissue\", \"Combinatorial regulation among factors not mapped\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Extended the transcriptional network to hormonal and stress inputs, establishing TRbeta/PGC-1alpha, C/EBPbeta, p38/PPARgamma, and insulin/Akt-FOXO1 as PDK4 regulators.\",\n      \"evidence\": \"ChIP, binding-site mutagenesis, siRNA knockdown in hepatocytes, pharmacological pathway dissection in adipose, and hyperinsulinemic clamps with Akt/FOXO1 readouts\",\n      \"pmids\": [\"19948729\", \"21586575\", \"20739620\", \"16873695\", \"15026305\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cross-talk and hierarchy among coactivators not resolved\", \"Mostly rodent tissue, human regulation less defined\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Placed PDK4 as a metabolic node downstream of oncogenic and adhesion signaling, where its suppression sustains PDH flux and proliferation.\",\n      \"evidence\": \"ErbB2/Erk manipulation with PDK4 gain-of-function, metabolic flux, lipogenesis, and proliferation assays in ECM-attached/detached cells\",\n      \"pmids\": [\"21852536\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not establish whether PDK4 acts solely via PDC here\", \"In vivo tumor relevance not tested in this study\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Demonstrated that PDK4 induction drives pathological cardiac metabolic remodeling and dysfunction, validated by PDK4 deletion and pharmacological inhibition.\",\n      \"evidence\": \"FOXO1-driven PDK4 in RV hypertrophy with DCA reversal; PDK4 KO rescue of ANG II diastolic dysfunction with ex vivo flux; Doberman GWAS linking a PDK4 splice variant to dilated cardiomyopathy\",\n      \"pmids\": [\"23247844\", \"23396452\", \"22447147\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism connecting the canine splice variant to disease at protein level unresolved\", \"Tissue-specific contribution versus systemic effects not separated\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Uncovered the first non-canonical PDK4 function — a kinase-independent scaffolding role stabilizing CREB to drive RHEB/mTORC1 signaling.\",\n      \"evidence\": \"Co-IP, CREB stability and RHEB expression assays, mTORC1 activity, and xenograft tumor models\",\n      \"pmids\": [\"25164809\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab Co-IP without reciprocal structural mapping\", \"Whether this requires PDK4 catalytic activity not resolved\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Established PDK4 as the controlling switch between glycolysis and oxidative phosphorylation during cellular differentiation and progesterone-driven cardiac remodeling.\",\n      \"evidence\": \"Bidirectional PDK4 manipulation with lactate/ATP readouts in trophoblasts; 13C flux tracing with PDK4 blockade in pregnancy heart model\",\n      \"pmids\": [\"28814762\", \"28928113\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Upstream control beyond hCG/cAMP/PKA in trophoblast not fully mapped\", \"Long-term physiological consequences not addressed\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Revealed PDK4 as a survival and gluconeogenic regulator in liver via cytoplasmic p65 retention and an FAO/AMP/AMPK/CREB axis.\",\n      \"evidence\": \"PDK4-p65 Co-IP, KO mice, ChIP at TNF promoter, rescue by p65/TNFR1 inhibition; metabolic flux with etomoxir defining FAO-dependent AMPK/PDE4B/CREB signaling\",\n      \"pmids\": [\"29603325\", \"30065033\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether p65 retention is direct kinase activity or scaffolding unresolved\", \"Tissue specificity of the apoptotic role not delineated\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Defined post-transcriptional m6A control of PDK4 and broadened its disease roles into autophagy-dependent vascular calcification, stem cell fate, and liver regeneration.\",\n      \"evidence\": \"m6A-seq, YTHDF1/eEF2/IGF2BP3 and WTAP binding assays, dm6ACRISPR; PDK4 manipulation in VSMC autophagy, LKB1 epistasis in intestinal stem cells, and PDK4 KO hepatectomy models\",\n      \"pmids\": [\"32444598\", \"37154586\", \"33203874\", \"31930988\", \"32258946\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative weight of transcriptional versus m6A control in vivo unclear\", \"Whether non-canonical roles share a common molecular basis not addressed\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Identified PDK4 as a dominant determinant of ferroptosis resistance, linking PDC inhibition to suppression of lipid-peroxidation substrate supply.\",\n      \"evidence\": \"Unbiased siRNA metabolic-enzyme screen, PDH activity and fatty acid synthesis assays, lipid peroxidation readouts, and high-fat diet mouse model in pancreatic carcinoma\",\n      \"pmids\": [\"33626342\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Generality across other tumor types not tested here\", \"Interaction with established ferroptosis machinery (GPX4) not mapped\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Demonstrated a PDC-independent kinase function: PDK4 phosphorylates SEPT2 to recruit DRP1 and drive mitochondrial fission.\",\n      \"evidence\": \"Phosphoproteomic substrate screen, SEPT2 phosphomutants, DRP1 localization, and rescue of mitochondrial dynamics in mitofusin 2-deficient cells\",\n      \"pmids\": [\"35969774\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological contexts engaging this axis versus PDC inhibition not delineated\", \"Structural basis of SEPT2 recognition unknown\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Connected PDK4-driven glycolytic lactate to ROS-dependent senescence signaling, defining its role in the senescence-associated secretory phenotype.\",\n      \"evidence\": \"PDK4 knockdown/inhibition, lactate/ROS/NOX1 readouts, SASP measurement, and in vivo tumor and aging models\",\n      \"pmids\": [\"37903887\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether the lactate-NOX1 link is direct not fully resolved\", \"Therapeutic window of PDK4 inhibition in aging not defined\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Expanded the non-canonical phosphorylation repertoire and partner interactions, with PDK4 phosphorylating HDAC8 to suppress CD20 and interacting with SIRT1 to promote glycolysis.\",\n      \"evidence\": \"HDAC8 Ser-39 phosphorylation with CD20 deacetylation in resistant DLBCL; SIRT1-PDK4 Co-IP with bidirectional PDK4 manipulation in decidualization\",\n      \"pmids\": [\"39004737\", \"39080028\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab studies without reciprocal structural validation\", \"Whether nuclear PDK4 pool is functionally distinct from mitochondrial pool unresolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unresolved how PDK4 partitions between its mitochondrial PDC-inhibitory role and its cytoplasmic/nuclear non-canonical activities, and what governs substrate choice among PDC, SEPT2, HDAC8, CREB, p65, and SIRT1.\",\n      \"evidence\": \"No single study reconciles the subcellular localization, catalytic-versus-scaffolding modes, and substrate selection across contexts\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No unifying model for localization-dependent function\", \"No structural determinants of non-PDC substrate selection identified\", \"Relative in vivo contribution of canonical versus non-canonical roles unquantified\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 31, 34]},\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [0, 31, 34]},\n      {\"term_id\": \"GO:0140097\", \"supporting_discovery_ids\": []},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [13, 20]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [0, 31]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [20]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [34]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [0, 23, 28]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [13, 20, 21]},\n      {\"term_id\": \"R-HSA-1852241\", \"supporting_discovery_ids\": [31]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [20, 28]},\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [32]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"PDHA1\", \"SEPT2\", \"DRP1\", \"CREB\", \"RELA\", \"HDAC8\", \"SIRT1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}